Electrogenerated Chemiluminescent Studies of 9,10-Diphenylanthracene, Rubrene, Tris(2,2\u27-Bipyridine)Ruthenium(Ii) Species, and Their Derivatives For Sensitive Detection of Biomolecules by Bastola, Pradip
The University of Southern Mississippi 
The Aquila Digital Community 
Dissertations 
Summer 2017 
Electrogenerated Chemiluminescent Studies of 
9,10-Diphenylanthracene, Rubrene, Tris(2,2'-
Bipyridine)Ruthenium(Ii) Species, and Their Derivatives For 
Sensitive Detection of Biomolecules 
Pradip Bastola 
University of Southern Mississippi 
Follow this and additional works at: https://aquila.usm.edu/dissertations 
 Part of the Analytical Chemistry Commons 
Recommended Citation 
Bastola, Pradip, "Electrogenerated Chemiluminescent Studies of 9,10-Diphenylanthracene, Rubrene, 
Tris(2,2'-Bipyridine)Ruthenium(Ii) Species, and Their Derivatives For Sensitive Detection of Biomolecules" 
(2017). Dissertations. 1429. 
https://aquila.usm.edu/dissertations/1429 
This Dissertation is brought to you for free and open access by The Aquila Digital Community. It has been accepted 
for inclusion in Dissertations by an authorized administrator of The Aquila Digital Community. For more 
information, please contact Joshua.Cromwell@usm.edu. 
ELECTROGENERATED CHEMILUMINESCENT STUDIES OF 9,10-
DIPHENYLANTHRACENE, RUBRENE, TRIS(2,2'-BIPYRIDINE)  
RUTHENIUM(II) SPECIES, AND THEIR DERIVATIVES FOR  
SENSITIVE DETECTION OF BIOMOLECULES 
 
 
 
 
 
by 
 
Pradip Bastola 
 
 
A Dissertation 
Submitted to the Graduate School, 
the College of Science and Technology, 
and the Department of Chemistry and Biochemistry 
at The University of Southern Mississippi 
in Partial Fulfillment of the Requirements 
for the Degree of Doctor of Philosophy 
 
August 2017 
ELECTROGENERATED CHEMILUMINESCENT STUDIES OF 9,10-
DIPHENYLANTHRACENE, RUBRENE, TRIS(2,2'-BIPYRIDINE)  
RUTHENIUM(II) SPECIES, AND THEIR DERIVATIVES FOR  
SENSITIVE DETECTION OF BIOMOLECULES 
by Pradip Bastola 
August 2017 
 
Approved by: 
 
________________________________________________ 
Dr. Wujian Miao, Committee Chair 
Associate Professor, Chemistry and Biochemistry 
 
________________________________________________ 
Dr. J. Paige Buchanan, Committee Member 
Research Physical Scientist, US Army Corps of Engineers 
 
________________________________________________ 
Dr. Song Guo, Committee Member 
Assistant Professor, Chemistry and Biochemistry 
 
________________________________________________ 
Dr. Douglas S. Masterson, Committee Member 
Associate Professor, Chemistry and Biochemistry 
 
________________________________________________ 
Dr. Karl J. Wallace, Committee Member 
Associate Professor, Chemistry and Biochemistry 
 
________________________________________________ 
Dr. Sabine Heinhorst, Chair 
Professor, Chemistry and Biochemistry 
________________________________________________ 
Dr. Karen S. Coats 
Dean of the Graduate School 
  
COPYRIGHT BY 
Pradip Bastola 
2017 
 
Published by the Graduate School  
 
 ii 
ABSTRACT 
ELECTROGENERATED CHEMILUMINESCENT STUDIES OF 9,10-
DIPHENYLANTHRACENE, RUBRENE, TRIS(2,2'-BIPYRIDINE)  
RUTHENIUM(II) SPECIES, AND THEIR DERIVATIVES FOR  
SENSITIVE DETECTION OF BIOMOLECULES 
 
by Pradip Bastola 
August 2017 
This dissertation explored and investigated the coreactant electrogenerated 
chemiluminescent (ECL) properties of unmixed and mixed systems of highly efficient 
ECL emitters, such as 9,10-diphenylanthracene (DPA), rubrene (RUB), and tris(2,2′-
bipyridine)ruthenium(II) [(Ru(bpy)3
2+)] species as well as their water-soluble derivatives, 
which can serve as ECL labels for sensitive bioanalysis of single or multiple analytes. 
The screening of most favorable common ECL coreactants, their concentration effects 
along with the effect of working electrode materials on ECL behavior, and energy 
transfer related interactions between ECL emitters were systematically investigated. In 
addition, a strategy for improvement of ECL signals with the use of nitrate salt as an ECL 
enhancing agent was employed. A highly sensitive and selective immunosensor for the 
detection of viruses (zika virus or ZIKV and dengue virus or DENV4) has been 
developed. 
A well-adaptable spectral ECL instrument that can be used for undergraduate 
analytical chemistry or instrumental analysis laboratories was first constructed. ECL 
 iii 
coreactant screening studies concluded that benzoyl peroxide (BPO) was the most 
suitable coreactant using Pt working electrode. 
Water soluble analogues of DPA and RUB, i.e., DPAS and SRUB, were 
synthesized and characterized by electrochemical and ECL studies. ECL signals were 
enhanced by more than 10 times when a nitrate salt was added to anodic ECL systems. A 
nitrate radical was seen using electron paramagnetic resonance (EPR) spectroscopy, 
which supported the proposed ECL enhancement mechanism was obtained.  
Efforts were made on looking for direct evidence of ECL coreactant intermediates 
using EPR spectroscopy. Benzyloxy free radical (C6H5CO2
• or BPO•) and sulfate anion 
radical (SO4
-•) were detected using solid or solution-phase coreactant with or without a 
spin trapping agent 5,5-dimethyl-1-pyrroline-N-oxide (DMPO) under UV irradiation or 
through chemical reduction reactions.  
Finally, zika virus (ZIKV) is a globally emerging mosquito-transmitted flavivirus 
that can cause severe fetal abnormalities. Any serotype of dengue virus (DENV1-4) 
shows flu like illness. As such, a highly sensitive and specific ECL based immunoassay 
was developed for detection of ZIKV and DENV-4 in human biological fluids with an 
impressive detection limit of 1 PFU of ZIKV in 100 μL of saline, human plasma, or 
human urine.  
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CHAPTER I - INTRODUCTION AND BACKGROUND 
The essence of this dissertation is to study the electrochemical and 
electrogenerated chemiluminescent (ECL) properties of ECL emitters, namely 9,10-
diphenylanthracene (DPA), rubrene (RUB), and tris(2,2'-bipyridine)ruthenium(II) 
complex (Ru(bpy)3
2+) for their potential applications towards detection and quantification 
of biomolecules, such as antigens, viruses, and proteins. Their analysis could be realized 
by designing highly efficient ECL based biosensors involving the combination of the 
most favorable ECL emitters and coreactants. This chapter briefly reviews various 
electroanalytical techniques, ECL and its bio-detection, and spectroscopic methods 
associated with ECL studies. 
1.1 Electroanalytical Techniques 
Electroanalytical techniques are the analytical techniques that study to infer 
crucial information, such as concentration and chemical reactivity of the analyte of 
interest by measuring electrical responses in the form of e.g., current, charge, oxidation 
states, or potential. In other words, these techniques deal with the interaction of electricity 
and analyte (usually a chemical species) resulting in chemical change and production of 
electrical energy by chemical change. The most common process of carrying out 
electrochemical analysis is in an electrochemical cell containing electrodes.1-3 Depending 
upon which aspects of the cell are controlled, elctroanalytical techniques are classified as: 
(a) potentiometry (potential difference is measured in the absence of current flow), (b) 
coulometry (current is measured over time), and (c) voltammetry (current is measured 
with varying potential). 
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A wide range of studies employing electroanalytical techniques can be found in 
the literature (e.g., scifinder scholar). Recently electroanalytical techniques have been 
deployed for analyzing polyphenols in red wine,4 determination of anti HIV drugs,5 
identifying lead white pigment,6 analyzing food samples,7-14 pharmaceutical drug 
analysis,15-29 probing neurochemical mechanisms and brain chemistry,30-40 understanding 
of temperature effects on metal chemodynamics,41 environmental monitoring, 42-45 and 
analyzing carcinogenic polycylic aromatic hydrocarbons (PAHs).46 
1.1.1 Cyclic voltammetry 
Cyclic voltammetry (CV) is a versatile electroanalytical and potentiodynamic 
technique, which has been widely used in the understanding of organometallic,47-50 
organic,51-55 and  polymer chemistry.56-58 CV is a simple and widely employed technique 
to obtain qualitative as well as quantitative information of the redox process under 
study.59,60 For ferricyanide/ferrocyanide [FeIII(CN)6
3-]/FeII(CN)6
4-] system to demonstrate 
how this technique can be applied to fundamentally understand the redox process of this 
couple. The one electron redox process for ferricyanide/ferrocyanide can be written as: 
[FeIII(CN)6]
3- + e = [FeII(CN)6]
4-      (1.1) 
Nernst equation for Equation 1.1 can be expressed as: 
𝐸 =  𝐸Fe(CN)63−/Fe(CN)64−
0 + 0.059 log
[FeIII(CN)6
3−]
[FeII(CN)6
4−]
  (at 298 K)   (1.2) 
where E and E0′ are the measured and formal potentials, respectively. Figure 1.1 shows a 
cyclic voltammogram of K3Fe(CN)6 solution. The formal potential can be calculated as:  
 3 
E0′ = 
𝐸pa+𝐸pc
2
         (1.3) 
where Epa and Epc are the anodic and cathodic peak potential, respectively. The separation 
of peak potential of a reversible redox process: 
∆𝐸p = 𝐸pa − 𝐸pc =
0.057
𝑛
  (at 298 K)      (1.4) 
where n is the number of electron transfer involved in the redox process. For the process 
shown in Equation (1.1) n = 1, thus ΔEp = 57 mV is the expected value. 
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Figure 1.1 Cyclic voltammogram (CV) of K3Fe(CN)6. 
Note: Cyclic voltammogram was obtained from 6.0 mM K3Fe(CN)6 and 1.0 M KNO3 at a 3.0 mm-diameter glassy carbon working 
electrode at a scan rate of 100 mV/s. 
For a reversible system, the peak current on the forward scan (ip) is given by the 
Randles-Sevcik equation:2,61  
 4 
ip = (2.69×10
5) n3/2AD1/2Cv1/2       (1.5) 
where n is the number of electrons transfer involved, A is the surface area of electrode 
(cm2), D is the coefficient of diffusion (cm2/s), C is the concentration of the electroactive 
species (mol/cm3), and ν is the scan rate (V/s). Therefore, the magnitude of peak current 
is proportional to the concentration of analyte and the square root of scan rate. 
CV is often used to check the stability of reaction products, the presence of 
intermediates in redox reactions, electron transfer kinetics,62 and the reversibility of a 
reaction.63 CV is used to determine the electron stoichiometry of a system,64,65 the 
diffusion coefficient of an analyte and the formal reduction potential. Because the 
concentration is proportional to current in a reversible nernstian system, concentration of 
an unknown analyte can be determined by generating a calibration curve of current vs. 
concentration.66,67  
1.1.2 Differential pulse voltammetry 
Differential pulse voltammetry (DPV) is often the electrochemical technique of 
choice when the sensitivity of CV is not enough. In other words, if the redox peaks in CV 
are not obvious, one normally considers DPV technique to speculate where the 
electroactive species is oxidized or reduced. DPV is none other than the first order 
differentiation or derivative of linear sweep voltammetry or staircase voltammetry where 
a series of regular voltage pulses applied in a potential linear sweep or stairsteps fashion. 
Like all potentiometric methods, the current is measured immediately before each 
potential change. A differential pulse voltammogram is a plot of current change of each 
 5 
cycle of pulse vs. potential. During a potential step, the faradaic current decay is much 
slower than the charging current decay. Thus, all pulsed techniques could provide much 
sensitive and low detection limit results for quantifying an electroactive species as 
compared with linear scan or cyclic voltammetry. Figure 1.2 shows a typical potential 
waveform of DPV and its voltammogram, where τ is the time of each pulse cycle, tp is the 
pulse time, ∆Ep is the pulse potential, and ∆Es is the change in potential per cycle. 
 
Figure 1.2 Potential-excitation signals and voltammogram for DPV (from ref.68). 
Note: The current is sampled at the time intervals shown by the black rectangles. ∆i, the current changed is measured by current at 
point subtracted from the current at point 2. 
1.2 Electrogenerated Chemiluminescence 
Electogenerated chemiluminescence (ECL) is a light emission process as a 
consequence of electrochemical reaction and is generally potential (voltage) controlled. 
The wavelength of the emitted light corresponds to the energy gap between the excited 
and ground states of the emitter (luminophore). ECL emitters can be organic, such as 
dipyrometheneboron difluoride (BODIPY) as shown in Figure 1.3 (a), inorganic metal 
complexes, such as tris(2,2'-bipyridine)osmium(II) [(Os(bpy)3
2+)] as shown in Figure 1.3 
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(b), and semiconductor nanoparticles (quantum dots), such as CdSe/ZnS quantum dots as 
shown in Figure 1.3 (c). ECL has been classified into two main categories, namely ion 
annihilation ECL and coreactant ECL. 
 
Figure 1.3 Molecular structures of some common ECL emitters  
Note: Molecular structures of (a) BODIPY, (b) Os(bpy)3
2+, and (c) cartoon representation of CdSe (ZnS shell) quantum dot. 
1.2.1 Ion annihilation ECL 
ECL has been investigated since 1960s as a method of producing light at an 
electrode,69 and has been widely used in analyte binding studies.70-72 A typical ECL 
process is illustrated in Scheme 1.1, where species A accepts an electron at the cathode to 
form a reductive species A-, while species D loses an electron at the anode to form an 
oxidative species D+. When both A- and D+ species diffuse from the electrode and meet, a 
highly energetic electron transfer process from A- to D+ occurs, resulting in the formation 
of the excited state A* that emits light (i.e., ECL emission). The emitted light intensity is 
generally proportional to the ECL emitter’s concentration initially present in the solution, 
and the emission wavelength reflects the identity of the emitter. Based on the above two 
characteristic properties of an ECL system, qualitative and quantitative analysis of a 
target analyte associated with an ECL label can be realized. Because both radical anion 
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and cation are produced electrochemically before their annihilation to form ECL, this 
type of ECL is called ion annihilation ECL. Note that the chemical species used in ion 
annihilation ECL can be the same, for example, A = D = R (i.e., R = 9,10-
diphenylanthracene (DPA), rubrene (RUB), or tris(2,2'-bipyridine)ruthenium(II) 
(Ru(bpy)3
2+)). After one cycle ion annihilation process, the ECL emitter is regenerated 
resulting in high sensitivity of the technique. 
 
Scheme 1.1 Schematic diagram showing general principles of ion annihilation 
ECL process.73 
Equations (1.6-1.9) list each step of a typical type of ion annihilation ECL. 
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R – e →  R•+                    (oxidation)      (1.6) 
R + e →  R•−                   (reduction)      (1.7) 
R•+ + R•− →  R +  R∗      (ion annihilation)     (1.8) 
R∗  →  R + hν                   (light emission)     (1.9) 
Depending on the energy available in an ion annihilation, Equation 1.8, the produced R* 
could be either the singlet state species (1R*) or the triplet state species (3R*). 
Instead of two working electrodes, in which one is applied with a positive 
potential and the other with a negative potential, ion annihilation ECL can also obtained 
from an electrochemical system with only one working electrode. In this case, however, 
the working electrode must be scanned or pulsed between a positive and a negative 
potential alternatively. When R•+ or R•- species is not stable enough for ECL reaction, or 
when the ECL solvent has a narrow potential window (e.g., in aqueous solution) so that 
R•+ or R•- cannot be formed, no or weak ECL emission can be produced via the ion 
annihilation pathway. 
The energy available or enthalpy for ion annihilation in Equation 1.8 can be 
estimated using modification of the standard Gibbs-Helmholtz equation, G =H - TS 
from the redox potential for oxidation and reduction processes in Equations 1.6 and 1.7 
using 
−∆𝐻ann = 𝐸p (
R
R•+
) − 𝐸p (
R
R•−
) − 0.16      (1.10) 
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where −∆𝐻ann is measured in eV. 𝐸p is the peak potential (in volts) for electrochemical 
redox process. The numerical value of 0.16 in Equation 1.10 is the entropy approximation 
term (TS). If the energy (−∆𝐻ann) is larger than the energy required for the formation 
of lowest excited singlet state and is said to follow “energy sufficient” or S-route, 
otherwise it is called “energy deficient system” and follow T-route. If neither route 
persists, a third route called ST route arises. 
The ion annihilation for S route is summarized as: 
R•+ + R•− →  R + R∗1    (singlet excited state formation) (1.11) 
In contrast, the ion-ion annihilation for T route is summarized as: 
R•+ + R•− →  R + R∗3         (1.12) 
R3 ∗ + R3 ∗  →  R + R∗1         (1.13) 
9,10-diphenylanthracene (DPA) system, more specifically, DPA•+/DPA•- system 
displays the typical S route system,74,75 whereas N,N,N′,N′-tetramethyl-p-
phenylenediamine/9,10-diphenylanthracene, i.e. TMPD•+/DPA•- generates the excited 
state utilizing the T-route.75,76 ST route is usually adopted by RUB•+/RUB•- system.77-80 
1.2.2 Coreactant ECL 
To overcome the aforementioned problems, coreactant ECL strategies can be 
used,72,81,82 in which ECL is generated from a system containing an ECL emitter (e.g., 
Ru(bpy)3
2+) and a deliberately added substance called coreactant (e.g., tri-n-propylamine 
 10 
(TPrA), or benzoyl peroxide (BPO)) upon anodic or cathodic potential scanning or 
pulsing. Chemically, a coreactant is a species that, upon electrochemical oxidation or 
reduction, immediately undergoes chemical decomposition to form a strongly reducing or 
oxidizing intermediate that can react with an oxidized or reduced ECL emitter to generate 
excited states. Use of coreactant ECL allows many ECL related studies to be able to 
conduct in aqueous media. Depending on the electrode potential scanning direction, 
coreactant ECL can be classified as either anodic coreactant ECL or cathodic coreactant 
ECL.81 In fact, coreactants are the intermediate species when electrochemically oxidize 
or reduce yield high redox power radical species for further chemical reactions in ECL 
processes. This ECL route has been used to enhance ECL greatly even for strong ECL 
emitters such as Ru(bpy)3
2+. Figure 1.4 shows three commonly used ECL coreactants. 
 
Figure 1.4 Molecular structures of some common ECL coreactants.  
Note: (a) Tri-n-propylamine (TPrA), (b) oxalate, and (c) persulphate salt. 
The used coreactant should not itself generate any ECL, otherwise there would be 
an interference with the analyte in solution. Additionally, the oxidation and reduction of 
the coreactant and analyte should be simultaneous after which there occurs chemical 
reaction followed by the electrochemical redox reaction at the surface of the electrode. As 
demonstrated in Scheme 1.2, the coreactant approach was first introduced by Bard et al., 
where ECL was studied in acetonitrile in the absence and presence of several 
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luminophores such as rubrene, DPA, Ru(bpy)3
2+, and Os(bpy)3
2+. TPrA and oxalate 
belong to the class of anodic ECL coreactants, whereas BPO and persulfate belong to the 
class of cathodic ECL coreactants. As shown in Scheme 1.2a., electrochemical oxidation 
of oxalate and Ru(bpy)3
2+ occurs simultaneously in the anodic region (upon application 
of positive potential), a strong reducing agent, CO2
•– with a high reduction power is then 
produced after oxidized. Thus, in situ formed radical anion undergoes e.g., chemical 
reaction with the oxidized cation Ru(bpy)3
3+ to yield the excited state of Ru(bpy)3
2+( i.e., 
Ru(bpy)3
2+*) generating ECL.  
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Scheme 1.2 Coreactant mechanisms route in typical ECL processes. (from 
ref.71,83). 
Note: ECL mechanistic pathways for Ru(bpy)3
2+ with both reductive ((a) Oxalate, (b) TPrA) and oxidative ((c) persulfate, (d) BPO) 
coreactants. 
Similarly, the oxidation of TPrA and Ru(bpy)3
2+occurs simultaneously in the 
anodic region, a strong reducing agent TPrA• with a high reduction power is produced 
after oxidized. This TPrA• free radical produced chemically after deprotonation 
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encounters the oxidized cation Ru(bpy)3
3+ to yield the excited state Ru(bpy)3
2+ (i.e., 
Ru(bpy)3
2+*) producing ECL as illustrated in Scheme 1.2b. 
The ECL mechanism with cathodic coreactants, such as BPO and persulfate, is 
completely reverse to that of ECL mechanism of anodic coreactants described previously. 
With cathodic coreactant, such as persulfate (S2O8
2-), the reduction of persulfate and 
Ru(bpy)3
2+ occurs simultaneously at the cathode, a strong oxidant, SO4
•- with a high 
oxidizing power, is then produced after reduction. Thus, SO4
•- anion free radical 
produced encounters reduced cation Ru(bpy)3
+ to form the excited state of Ru(bpy)3
2+ 
(i.e., Ru(bpy)3
2+*) producing ECL as seen in Scheme 1.2c. Similarly, when BPO is used 
as cathodic ECL coreactant, the reduction of BPO and Ru(bpy)3
2+ occurs simultaneously 
at the cathode, a strong oxidant, BPO•- with a high oxidizing power is then produced after 
reduction of BPO. BPO•- quickly undergoes chemical decomposition to yield BPO• free 
radical that chemically reacts with the reduced cation Ru(bpy)3
+ to yield the excited state 
of Ru(bpy)3
2+ (i.e., Ru(bpy)3
2+*) generating ECL as illustrated in Scheme 1.2d. 
1.3 Unique Features of ECL69,71 
ECL bridges the traditional fields of analytical electrochemistry with 
luminescence spectroscopy, and offers several distinct advantages over other 
spectroscopic-based detection system. 
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(1) Compared with fluorescence (FL) methods, ECL does not need a light source, 
which effectively frees the ECL from scattered-light and luminescent impurity 
interferences. 
(2) Although ECL is a form of chemiluminescence (CL), in which both ECL and 
CL involve the light production by species that can undergo highly energetic electron 
transfer reactions. CL is initiated by the mixing of needed reagents with carefully 
controlling of their fluid flows. In contrast, ECL stars with electrochemical reactions by 
controlling electrode potential, scan rate, and position.  
(3) ECL can be more selective than CL because the type of excited states may be 
controlled by varying the electrode potential. 
(4) ECL generally is a nondestructive technique, in which the ECL emitter can be 
re-generated after the ECL emission, thereby providing high sensitivity. 
The above statements are supported by several recent studies,84-86 where different 
immunoassays based on enzyme-linked immunosorbent assay (ELISA), 
chemiluminescence (CL), ECL, and FL were compared, and ECL-based immunoassays 
were found to have excellent reproducibility and sensitivity over other assays. Therefore, 
ECL-based sensing systems will offer several unique features, which include high 
sensitivity, good selectivity, low background, integrated versatility, excellent 
reproducibility, and fast sample analysis. 
1.4 Implications of ECL 
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Sensitivity and selectivity are desirable attributes of any ECL based detection 
system for detecting specific molecules of interest with many components. Sensitivity, in 
DNA hybridization and other bioassays for the detection of biomolecules of interest, is 
important in clinical diagnostics,87-90 forensic chemistry,90,91 environmental 
investigations,92,93 pharmaceutical studies,94,95 and biological warfare agent detection.96-
103 Thus, ECL provides sensitive and selective detection of molecules of interest should 
have broad applicability in all of these fields. A number of ECL reviews83,104-115 have 
been available as ECL has been aggressively employed in clinical diagnostics because of 
the sensitivity, selectivity, and stability of ECL based biosensors. 
Since ECL itself is not the stand alone technique, ECL needs to be coupled with 
various separation techniques, specifically liquid chromatographic techniques (high 
performance liquid chromatography or HPLC116-123, flow injection,124-129 capillary 
electrophoresis or CE130-135 ) for determination and analysis of analytes in matrix. 
Biological threat agents have been detected with ECL and fluorogenic-
chemiluminescence (FCL) based assays. ECL detection was found to be more sensitive 
for the detection of bacteria, viruses, and toxins whereas FCL has been considered as 
more versatile for effective sample clean-up and high throughput screening of complex 
samples. 
Magnetic beads based ECL assays have been used with conjecture with a 
technology called systematic evolution of ligands by exponential enrichment (SELEX).136 
Instead of using protein-based antibodies in most common immunoassay formats, highly 
specific receptors formed from oligonucleotides called aptamers have been utilized. 
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Numerous label free aptamer based ECL detection has been investigated.137-154 
Amplification of binding receptors can be procured via PCR (polymerase chain 
reaction).Various immobilization ECL formats (immunoassays as well as DNA 
hybridization) can be found in ECL literature utilizing classical ECL luminophores,155-161 
semiconductor nanoparticles or quantum dots (QDs),162-165 metal nanoparticles 
(NPs),105,166-171 carbon nanotubes (CNTs) 172-177 and graphene,139,178-186 for improving 
performance of developed ECL biosensors. Very sensitive and precise DNA assays 
labeled with Ru(bpy)3
2+ derivatives have been presented.187 Recent reports on DNA 
assays witnessed the limit of detection (LOD) as 20 DNA copies per mL in plasma or 
serum and 80 copies per mL in whole blood of varicella-zoster virus.188 On a separate 
paper, a threshold of 10 DNA copies of Epstein–Barr virus has been mentioned.189 
Quantification of DNA or messenger RNA by reverse transcription PCR based on 
Ru(bpy)3
2+-ECL has been performed using commercial QPCR System 5000® from 
Perkin–Elmer190 and the Origen® Analyser from Igen191 down to attomolar level 
immobilized on a solid support (magnetic beads) using biotin-streptavidin chemistry. 
Latest ECL applications include lab-on-a-chip approaches paper based ECL.192-195  
1.5 Selected Examples of Application of ECL for Detection of Analytes 
1.5.1 Analyte binding methods used in ECL based detection 
There is an increasing need for rapid, highly specific methods of detecting and 
quantifying small quantities of analytes such as chemical, biochemical, and biological 
substances. The presence of these materials can often be determined by binding methods 
that exploit the high degree of specificity which characterizes many biological systems. 
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Known methods that rely on binding to detect a molecule of interest in a sample include 
nucleic acid hybridization techniques and protein-ligand interactions such as antibody-
antigen binding (Figure 1.5).72 In these methods, a positive value is typically indicated 
either by the presence or the absence of an observable label (e.g., an ECL label) that has 
been attached to one or more of the materials comprising a diagnostic complex. For 
example, in the first case of DNA detection (Figure 1.5a), a target single-stranded DNA 
(ssDNA) with an ECL label attached hybridizes with a ssDNA probe that immobilized on 
a solid substrate.196,197 Under the same experimental conditions, ECL produced from the 
complementary ssDNA hybridization will be higher than that obtained from non-
complementary one. The sandwich type format shown in Figure 1.5d196,198 is the most 
commonly used means of ECL detection of an antigen (or a biomarker). Also, direct 
interaction between the capture antibody and corresponding labeled antigen is possible 
(Figure 1.5e), although in this case the pretreatment of the antigen (analyte) with the ECL 
label, and subsequent separation of the free ECL labels from the antigen-ECL label 
conjugates would be required, which could dramatically slow down the entire detection 
progress as compared with the sandwich type assays, where both surface-confined and 
ECL labeled antibodies can be pre-prepared. In a competition assay format (Figure 1.5f), 
the unlabeled antigen blocks the ability of the labeled antigen to bind. As a result, less 
label measured in the assay means more of the unlabeled (test sample) antigen is present. 
In other words, the amount of antigen in the test sample is inversely related to the amount 
of label measured in the competitive format.  
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Figure 1.5 Examples of solid-phase ECL assay formats (from ref.72). 
Note: (a) DNA hybridization assay based on an immobilized ssDNA hybridizes with a labeled target ssDNA., (b) sandwich type DNA 
biosensor, (c) an assay used for integrase activity test with immobilized and free labeled dsDNA, (d) sandwich type immunoassay, (e) 
direct immunoassay, (f) competitive assay in which analyte competes with labeled analyte for antibody binding sites on immobilized 
antibody, (g) protease activity assay where cleavage of the immobilized peptide results in the decrease in ECL emission due to the 
removal of the ECL label, (h) kinase activity assay using a labeled antibody to recognize the phosphorylated product. 
1.5.2 Sensitive detection of specific ion 
A new type of Hg2+ selective ECL biosensor with an extremely low detection 
limit of 2.4 pM and high stability has been recently reported on the basis of mercury-
specific oligonucleotide (MSO). MSO served as a molecular recognition element and a 
Ru(bpy)3
2+ derivative as an ECL emitting species. As shown in Figure 1.6, the MSO is 
covalently attached to the surface of carboxylated single-wall carbon nanotubes (SWNTs) 
on a glassy carbon electrode via an appropriate length of spacer. G4 PAMAM dendrimer 
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with heavily loaded Ru(bpy)3
2+ derivatives are tethered to the other end of the MSO. In 
the presence of Hg2+ ions, the initial linear MSO bends to form a “hairpin” type structure 
after the complexation reaction between Hg2+ ions and thymine bases, which leads to the 
ECL labels become closer to the electrode surface. Thus, a significant increase in ECL 
intensity was observed with the Hg2+ bound ECL biosensor upon the anodic potential 
scanning or pulsing in the presence of TPrA coreactant. 
 
Figure 1.6 Working principle of the Hg2+-ECL detection (from ref.199). 
 
1.5.3 “High amplification” strategy of ECL detection  
In ECL analysis, ECL active labels that are attached to the target biomolecule 
produce a measurable signal. The intensity of the measured signal is generally 
proportional to the amount of the target species bound on the electrode. Traditionally, 
only one or few labels can be attached directly to one target biomolecule, so that 
nonspecific adsorption can be avoided and the bioactivity of the target biomolecule 
remains. By utilizing polystyrene microspheres/beads (PSB) as the carrier of a large 
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number of hydrophobic ECL labels (i.e., Ru(bpy)3
2+) an ultrasensitive methodology for 
DNA hybridization detection,156 sandwich-type immunoassay of C-reactive protein 
(CRP),155 and the detection of high explosive 2,4,6-trinitrotoluene (TNT)-contaminated 
soil and creek water samples161 has been demonstrated.  
The principle of this type of strategy is shown in Figure 1.7. For DNA detection 
(Figure 1.7a), a known sequence ssDNA (probe ssDNA) is first immobilized on the 
surface of a magnetic bead (MB). The complementary ssDNA (target ssDNA)-coated 
PSB bead that contains a large number of ECL labels (e.g., water insoluble Ru(bpy)3
2+, 
~109 molecules/bead) hybridizes with the probe ssDNA to form a [(probe ssDNA-
MB)/(target ssDNA-PSB)] aggregate. Finally, this aggregate is magnetically separated 
from the reaction mixture and transferred into an acetonitrile (MeCN) solution, in which 
the PSBs dissolve and the ECL label is released. Light emission from the released ECL 
labels is subsequently measured in MeCN in the presence of a coreactant, such as TPrA, 
at a Pt electrode. A similar approach based on a sandwich-type of immunoassay can be 
used for the detection of an antigen (e.g., CRP and TNT), as displayed in Figure 1.7b. 
Clearly, there is no need for direct attachment of the ECL labels to ssDNA or antibodies 
in the present technique, therefore a high loading capacity of the ECL labels per PSB, 
hence a very large amplification factor of the ECL label molecules for each molecule of 
analyte can be achieved, given that a limited number of capture ssDNA or antibody 
species are attached to one PSB via the immobilization layer (of avidin). 
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Figure 1.7 Schematic diagram of (a) DNA hybridization, and (b) sandwich type ECL 
immunoassay (from ref.72). 
Note: Polystyrene beads were used as the ECL label carrier and magnetic beads were used for the separation of analyte-containing 
ECL label/polystyrene beads. 
With the above PSB-based “high amplification” technique, a detection limit of 1.0 
fM (1.0×10-15 M) for a t-ssDNA was achieved,197 along with a 100-fold improvement in 
the sensitivity in the CRP determination198 compared to a previously reported surface 
immobilized ECL method.196 Likewise, a limit of detection of 0.10 ppt TNT was 
obtained,200 which is about 600 times lower than recently reported data using “a novel 
surface plasmon resonance immunosensor.”201  
Similar idea has been extended to ECL detection in aqueous media. Instead of 10 
μm in diameter PSBs, ~100 nm in diameter sized liposomes as the ECL label carrier were 
used in CRP detection.202 The release of the ECL label from liposomes was realized by 
using 0.1 M TPrA and 0.1 M phosphate buffer (pH 7.6) containing 0.1 M NaCl and 1% 
(v/v) Triton X-100.  
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1.5.4 Lab on a chip and paper based ECL 
Recent advancement in the field of ECL has made possible an exciting invention 
of a kind of paper substrate micro-fluidic chip of bipolar electrode ECL and application 
in imaging and sensing. This can be realized in practice by utilizing carbon paste as 
bipolar electrode on paper for development of ECL chip for imaging, sensing, and 
detection of TPrA. This invention exploits the proof of concept of paper substrate micro-
fluidics. 
Another recent report203 described the development of an ECL sensor fabricated 
utilizing paper microfluidics with and without the use of conventional photodetectors. 
Paper based microfluidic sensor was designed with inkjet printing were combined with 
screen-printed electrodes (SPEs) to create simple, cheap, disposable using conventional 
as well as mobile phone camera. Using conventional photodetector, a LOD of 2-
(dibutylamino)ethanol (DBAE) and nicotinamide adenine dinucleotide (NADH) was 0.9 
μM and 72 μM, respectively, whereas 250 μM DBAE was detected using the phone. 
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Figure 1.8 Fabrication and operation of a paper-based microfluidic ECL sensor. (from 
ref.203). 
Note: The individual paper fluidic elements were cut to size and the hydrophilic portion filled with a 10 mM Ru(bpy)3
2+ solution 
before drying. The paper substrate was then aligned and fixed onto the face of the SPE by laminating with transparent plastic. Finally, 
a drop of sample is introduced through a small aperture in the plastic at the base of the channel, and when the detection zone was fully 
wetted, the sensor was placed close to the lens of the camera phone, a potential of 1.25 V was applied, and the resulting emission was 
captured and analyzed. 
A wide range of ultrasensitive detection of analytes using ECL can be found in 
the literature.113,138,143,148,153,156,161,204-206 
1.6 Ultraviolet-Visible Spectroscopy 
Ultraviolet–visible spectroscopy (UV-Vis or UV/Vis) is an absorption 
spectroscopic technique in which absorption of light intensity by a molecule in a sample 
in UV-Vis region. UV-vis technique is based on Beer’s law, which can be expressed as 
shown below in Equation 1.14 as: 
A = ɛ.b.C         (1.14)  
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where A is the absorbance, ɛ, the molar extinction coefficient (molar absorptivity) in the 
units of L mol-1.cm-1, b, the path length of the cuvette (cm), and C is the concentration in 
mol L-1. During an absorption process, an electron from the ground energy state promotes 
to the higher energy level of excited state. Because we measure the absorbed light by the 
sample of interest, the detector is aligned along with the light source and sample holder. 
1.6.1 Application of UV-Vis in ECL 
UV-Vis spectroscopy is employed to obtain an optimum fluorescence. For 
optimum fluorescence, one needs a right excitation wavelength that can be obtained by 
speculating at what absorption wavelength the molecule absorption is maximum in UV-
Vis spectra. This wavelength is often the correct excitation wavelength in fluorescence. 
UV-Vis spectroscopy could help us to understand the energy or electron transfer 
mechanism and has found many applications in biomolecule detection.181,207-211 
1.7 Fluorescenece Spectroscopy 
Fluorescence spectroscopy is an emission spectroscopic technique utilized to 
record florescence or emissive light from a sample when UV or visible light is externally 
applied to excite the electrons in a molecule. The energy of light emitted is the energy 
level difference between the lower and upper energy levels before and after the 
promotion of electron(s) by irradiation of external light source. Absorption and emission 
are the complementary processes. Because, light source is applied externally to excite the 
electrons, the emissive light or florescence is measured by placing the detector 90 degrees 
against the light source-sample array to measure the emitted light. 
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1.7.1 Application of fluorescence in ECL 
Theoretically, ECL emission spectrum could overlap with the fluorescence 
emission spectrum from the same luminophore under study. However, this is not always 
the case. For example, in the case of quantum dot luminophores that are not properly 
capped, there could be some shift in the peak emission wavelengths. To verify whether 
the ECL has been generated from the same luminophore or luminophore with some redox 
impurities contaminated with, one can compare the ECL spectrum with the fluorescence 
spectrum using identical solvent system. Absorption and emission are the crucial steps to 
understand the energy transfer between acceptor and donor molecules in mixed ECL 
emitter systems. One example of such energy transfer is the fluorescence resonance 
energy transfer (FRET) between two luminophores that emit light at two different or 
close emission wavelengths (Figure 1.8). One way of investigating this type of energy or 
electron transfer between two luminophores is to see if there is any spectral overlap 
between the emission of donor luminophore and the absorption of acceptor luminophore. 
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Figure 1.9 Schematic of FRET process (from ref.176). 
1.8 Electron Paramagnetic Resonance (EPR) Spectroscopy 
Electron paramagnetic resonance (EPR) or electron spin resonance (ESR) 
spectroscopy is a technique utilizing for studying materials with unpaired electrons. The 
fundamental principles behind EPR spectroscopy are analogous to that of nuclear 
magnetic resonance (NMR). EPR utilizes the excitement of electron spin whereas in 
NMR, the spins of atomic nuclei are excited. EPR offers great specificity because 
ordinary chemical solvents and matrices do not give rise to EPR spectra. For 
understanding origin of an EPR signal,212-215 the electronic levels of an atom in a 
molecule should be considered. Each electron has a magnetic moment and spin quantum 
number, s = 1/2, with magnetic components ms = +1/2 and ms = -1/2. In the presence of 
an external magnetic field with strength Bo, the electron’s magnetic moment aligns itself 
either parallel (ms = -1/2) or antiparallel (ms = +1/2) to the magnetic field (Figure 1.10), 
each alignment having a specific energy due to the Zeeman effect. The separation 
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between the lower and the upper state for unpaired free electrons is accompanied by 
either absorbing or emitting a photon of energy (ΔE) equal to hν such that the resonance 
condition is obeyed as shown in Equation 1.15. 
ΔE = hν         (1.15) 
where h is the Planck's constant (h = 6.626× 10-34 J•s) and 𝜈 is the frequency of the 
radiation. This leads to the fundamental equations of EPR spectroscopy:  
hν = geμBBo         (1.16) 
where ge equals to 2.0023 for the free electron and μB is the Bohr magneton. 
 
Figure 1.10 Energy diagram showing splitting of the energy levels is directly proportional 
to the strength of magnetic field. 
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1.8.1 Application of EPR in ECL 
ECL generation always involves anionic, cationic, and free radicals. As a result, 
EPR could play an important role in monitoring the reaction process and in providing 
critical information for proposing ECL mechanisms. Previously, EPR signals obtained 
from TPrA•+ cation radical after its oxidation has been reported.216 Very recently, 
hydroxyl radical OH•, which is an intermediate of cathodic ECL coreactant H2O2 
reduction, as well as its stability in H2O-CH3CN mixtures, has also been published.
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1.9 Scope of This Dissertation  
There has been ongoing rapid use of ECL in quantification and analysis of 
clinical, food, and environmental samples; however, there are very few studies found in 
the literature for ECL based multiplexed assays. Thus, there is a need for urgent and 
immediate measures to be taken to detect and quantify multiple analytes per assay with 
high throughput. One could save time, money, and effort by collecting multiple data at 
one time with the use of multiple emitters (labels). For this, it is important to study the 
systematic ECL titration behavior of mixed and unmixed systems of multiple efficient 
ECL emitters before their potential applications in multiplexing detection of 
biomolecules could be realized. This dissertation focuses on search for favorable ECL 
coreactants by screening various commonly used ECL coreactants that suit in both 
unmixed and mixed systems of emitter-coreactant combination. This dissertation also 
provides insights into optimizing experimental conditions, which include effects of 
electrode material, molecular oxygen (only applicable to cathodic coreactants), 
concentration of ECL emitter, coreactant, and solvent on ECL signal intensities. The 
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interaction studies of the multiple efficient ECL emitters with common favorable 
coreactant in their mixed systems are also the focused area of this dissertation. The 
synthesis of water soluble analogues of DPA and RUB, viz. 9,10-diphenylanthracene 
sulfonate (DPAS) and sulfonated rubrene (SRUB), electrochemical and ECL studies of 
the synthesized emitters, and methods to improve ECL signals of the emitters all comes 
under the scope of this dissertation. EPR studies of ECL coreactant intermediates of 
cathodic ECL coreactants, namely benzoyl peroxide and persulfate, that generate 
benzoyloxy free radical (BPO•) and sulfate anion radical (SO4
•̶̶̶̶) were conducted.  Finally, 
sensitive and selective ECL detection of zika and dengue viruses is achieved with the use 
of effective and efficient emitter-coreactant combination. 
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CHAPTER II - COREACTANT ECL STUDIES OF UNMIXED AND MIXED 
SYSTEMS OF 9,10-DIPHENYLANTHRACENE, RUBRENE, AND TRIS(2,2'-
BIPYRIDINE)RUTHENIUM(II) IN ACETONITRILE 
2.1 Introduction 
A biosensor is an analytical device for detection and quantification of biological 
species (e.g., bacteria, viruses, antigens, enzymes, nucleic acids) through a variety of 
transducers that convert chemical information (e.g., identity and concentration of analyte) 
into a measurable signal (e.g., current, voltage, mass change, and optical intensity). 
Electrogenerated chemiluminescence (ECL) based biosensors use the ECL emission to 
probe target biomolecules. The Ru(bpy)3
2+-TPrA system has been the most commonly 
used coreactant ECL system in the literature for determination of various analytes,1-
20 although the Ru(bpy)3
2+-DBAE (DBAE = 2-(dibutylamino)ethanol) system has 
recently shown some promising results.21-29 To measure multiple analytes in a sample 
simultaneously, a multiplexing detection method must be developed. When ECL is used 
as a sensing element, multiple efficient ECL emitters present in the same sample matrix 
could be required. Spectroscopically, however, how these ECL emitters interact each 
other in the same solution under the ECL experimental conditions remains unclear.  
ECL is a relatively new analytical technique, which has vast applications in the 
areas of e.g., (a) life sciences for the discovery of new drugs and important biological 
markers, (b) clinical utilities such as screening, monitoring, and diagnosing specific 
biomolecules associated with certain types of diseases, and (c) industrial management 
and bio-defense for monitoring and identification of bacteria, toxins, chemical warfare 
agents, explosives, and other pathogens in food and environmental samples.218 It would 
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be beneficial to college students majoring in e.g., chemistry, biochemistry, forensic 
chemistry, and environmental sciences to be exposed to ECL technology. However, the 
current textbooks of analytical and instrumental analysis lack the relevant contents. In 
fact, ECL theory and ECL labs could fit perfectly with any modern analytical chemistry 
especially instrumental analysis textbooks. This is because, scientifically, ECL is a 
perfect connection among the three-traditional instrumental analysis course components 
— spectroscopy, electrochemistry, and separation methods. ECL is a process of light 
generation (spectroscopy) via redox reactions (electrochemistry), and has been used as a 
transducer (detector) in flow injection, liquid chromatography, and capillary 
electrophoresis (separation methods) and micro total analysis.  
In this chapter, ECL behavior of unmixed and mixed systems of three efficient 
ECL emitters, namely 9,10-diphenyanthracene (DPA), rubrene (RUB), and Ru(bpy)3
2+, is 
studied with several common ECL coreatants, using an inexpensive homemade 
electrochemical-ECL-spectroscopic instrument. The data obtained will provide some 
fundamental information for future use in multiplexing ECL detection, and the 
constructed instrument can be used for college level ECL labs in instrumental analysis. 
Such electrochemistry-ECL-spectroscopy integrated labs will offer several advantages 
including (a) more efficient utilization of laboratory equipment, and (b) challenging 
students with critical thinking of different categories of instrumental techniques. 
Previously, there have been some efforts on constructing and conducting ECL labs for 
college students.219,220 The instrumentation and experiments presented in this chapter, 
however, are new.  
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2.2 Experimental Section 
2.2.1 Chemicals 
Unless otherwise stated, all chemicals were of analytical grades and used as 
received. Tris(2,2′-bipyridyl)ruthenium perchlorate [Ru(bpy)3(ClO4)2], tri-n- propylamine 
(TPrA, 99+%), rubrene (RUB, 98%), hydrochloric acid (HCl, 37.5%), benzoyl peroxide 
(BPO, 97%), and 2-(dibutylamino)ethanol (DBAE, 99%) were purchased from Sigma 
Aldrich (St. Louis, MO). Methanol (spectroanalyzed grade), 9,10-diphenylanthracene 
(DPA, 98%), and tetra-n-butylammonium perchlorate (TBAP, 99+%, electrochemical 
grade) were obtained from Fluka (Milwaukee, WI). Acetonitrile (MeCN, 99.93+%, 
HPLC grade) was purchased from MP Biomedicals (Solon, OH). 
2.2.2 Spectral ECL Instrument Setup 
The schematic diagram of spectral ECL instrument setup is shown in Figure 2.1, 
where a portable “WaveNow” potentiostat (Pine Research Instrumentation) is coupled 
with a Hamamatsu TG-series mini-spectrometer (Hamamatsu Photonics Inc.).221 A laptop 
computer installed with “AfterMath” software from Pine Instrumentation and 
“SpecEvaluation” software from Hamamatsu was used to control both the potentiostat 
and mini-spectrometer as well as to display both the electrochemical responses and ECL 
spectra. The connection between the computer and potentiostat or mini-spectrometer was 
done with a USB cable. ECL emissions generated at the working electrode were collected 
and sent to the mini-spectrometer via an optical fiber before displayed on the computer 
screen. Note that when electrochemical and ECL experiments were conducted, both 
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“AfterMath” and “SpecEvaluation” software must be open and run simultaneously. For 
the electrochemical cell system, either a screen-printed electrode (SPE, e.g., ceramic Au 
or Pt SPEs) or a traditional three-electrode system can be used.  
The above constructed spectral ECL instrument is relatively inexpensive, easy to 
operate, very portable, and well adaptable to various levels of teaching and learning 
environments.  
 
Figure 2.1 Schematic diagram of spectral ECL instrument setup. 
Note: (A) computer, (B) potentiostat/galvanostat, (C) electrochemical cell with a three-electrode system, and (D) mini-spectrometer. 
2.2.3 Electrochemical and ECL measurements 
A traditional three-electrode electrochemical cell system was used, with either a 
Pt (2.0 mm), Au (2.0 mm), or glassy carbon electrode (GCE, 3.0 mm) as the working 
electrode, a Ag/Ag+ (10 mM AgNO3 in 0.10 M TBAP in MeCN) as the reference 
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electrode, and a Pt mesh as the counter electrode, respectively. All these electrodes were 
purchased from CH Instruments (Austin, TX). A disposable 5 mL glass vial was used as 
the cell. The working electrode was polished with 0.3 µm alumina and washed with 
deionized (DI) water (Elix Advantage Water Purification System, EMD Millipore, 
Darmstadt, Germany), and sonicated in nitric acid and toluene, respectively. This was 
followed by rinsing the electrode with ethanol, DI water, and acetonitrile, respectively, 
and then drying with Kimwipes tissue. The vycor tip of the Ag/Ag+ reference electrode 
was replaced whenever needed to prevent from susceptible cross contamination. All 
solutions involving cathodic reduction reactions were pre-degassed with ultrapure 
nitrogen gas (Airgas, Hattiesburg, MS), and all experiments were conducted at room 
temperature 20 ± 1 °C. 
2.3 Results and Discussion 
2.3.1 Selection of ECL emitters and their CV studies 
There are a huge number of ECL emitters reported in the literature. For this study, 
however, 9,10-diphenylanthracene (DPA), rubrene (RUB), and Ru(bpy)3(ClO4)2 (Figure 
2.2) were chosen, because (a) they are readily available commercially, (b) they have 
shown well defined reversible redox behavior in acetonitrile (MeCN) that is the most 
commonly used organic solvent for electrochemical and ECL studies, (c) the ion 
annihilation ECL data indicated that their ECL efficiencies are among the highest in the 
ECL emitters ever studied, and (d) their ECL emission spectra are well separated from 
one to another, which is desirable for spectral separation based multiplexing ECL 
detection. Table 2.1 lists the redox potential, ECL efficiency, and ECL emission values of 
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DPA, RUB, and Ru(bpy)3
2+ species. Note that 25% efficiency for DPA represents the 
theoretical maximum for ECL from DPA singlets.222 Although the counter ion of 
Ru(bpy)3
2+ will not affect the ECL behavior, to avoid possible influence of water, 
Ru(bpy)3(ClO4)2 rather than hydrated Ru(bpy)3Cl2• 6H2O was used. 
 
Figure 2.2 Molecular structures of ECL emitters under study (a) DPA, (b) RUB, and (c) 
Ru(bpy)3
2+. 
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Table 2.1 Redox potential, ECL efficiency, and ECL emission values of DPA, RUB, and 
Ru(bpy)3
2+ species. 
 
ECL 
Labels 
Redox Potential (V, vs SCE) 
 
Ion 
Annihilation 
ECL 
efficiency 
ECL 
 
ECL Emission 
 (max, nm) 
E1/2(ox)  E1/2(red)   
Media 
Ref. 
223 
This 
work 
Ref. 
223 
This 
work 
Ref. 224 This 
work 
DPA +1.29 +1.03 -1.96 -2.24 MeCN 25%222 ~420 ~420 
RUB +0.82 +0.84 -1.56 -1.79 1:1 
MeCN
/PhH 
25%225 ~540 ~545 
 Ru(bpy)3
2+ +1.35 +1.05 -1.32 -1.63 MeCN 5%226 ~620 ~630 
 
Figure 2.3 shows the cyclic voltammograms of DPA, RUB, and Ru(bpy)3
2+, 
respectively, in which a mixed solvent system of MeCN/PhH (1:1, v/v) is used for RUB 
study due to its poor solubility in pure MeCN solvent (< 100 μM). Although benzene and 
phenolic moieties help increase solubility of RUB but could quench ECL significantly.227-
229 All three ECL emitters undergo reversible one-electron transfer oxidation and 
reduction reactions. It is believed that Ru(bpy)3
2+ oxidation occurs at the metal center, 
i.e., [RuII(bpy)3
2+]  [RuIII(bpy)32+], whereas the reversible three one-electron transfer 
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processes are contributed to the reduction of the bpy ligand.230  Table 2.1 lists the half-
wave potential of the first oxidation and reduction process of the three emitters, where a 
potential value of 0.186 V vs standard hydrogen electrode (SHE) for Ag/Ag+ (10 mM) in 
MeCN and 0.241 V vs SHE for saturated calomel reference electrode (SCE, Hg/Hg2Cl2 
(sat., KCl)) was used, respectively, for the conversion of the redox potential.2 Close 
inspection of Table 2.1 reveals that the redox potential difference between the oxidation 
(E1/2(ox)) and reduction (E1/2(red)) is nearly identical when comparing the literature value 
with the one of this work for both DPA (3.25 vs 3.27 V) and Ru(bpy)3
2+ (2.67 vs 2.68 
V),. This suggests that the difference in E1/2 value for the same redox process between the 
literature value and the present one is due to the use of two different reference electrodes. 
For RUB, however, a ΔE1/2 value of 2.38 V and 2.63 V is obtained from the literature and 
present work, respectively. Considering the ECL emission of RUB at ~540 nm and 
Ru(bpy)3
2+ emits at ~620 nm, one would expect a larger energy gap (or ΔE1/2 value) 
between the excited and ground state for RUB as compared with that for Ru(bpy)3
2+. 
Thus, for RUB the E1/2 values obtained from the present work are more reasonable.  
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Figure 2.3 CVs of individual ECL emitters. 
Note: CVs of (A)1.0 mM DPA in 0.10 M TBAP in MeCN, (B) 1.0 mM RUB in MeCN/PhH (1:1, v/v), and (C) 1.0 mM 
Ru(bpy)3(ClO4)2 at a 2-mm Pt electrode with a scan rate of 100 mV/s. 
2.3.2 Selection of ECL coreactants and working electrodes 
ECL coreactants are important species that are deliberately added into ECL 
emitter systems for obtaining efficient ECL emissions and ruling out the setbacks of 
working with solvents that cannot withstand a large potential window. They can also 
often overcome the problems associated with the instability of electrochemically 
generated emitter cations or anions or the ECL quenching by oxygen in the air.   
Tri-n-propylamine (TPrA) and 2-(dibutylamino)ethanol (DBAE) are commonly 
used for anodic ECL, and benzoyl peroxide (BPO) and persulfate are for cathodic ECL. 
Figure 2.4 shows the molecular structures of TPrA, DBAE, and BPO. As persulfate salt, 
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such as ammonium persulfate or potassium persulfate is not soluble in acetonitrile, only 
the three coreactants shown in Figure 2.4 were used for further studies.  
 
Figure 2.4 Molecular structures of ECL coreactants under study (a) TPrA, (b) DBAE, and 
(c) BPO. 
The cyclic voltammograms of individual coreactants under study are shown in 
Figure 2.5. At a Pt electrode, TPrA oxidizes at an onset potential of 0.20 V Ag/Ag+ and a 
peak potential of 0.49 V vs Ag/Ag+ (Figure 2.5a). Similarly, an onset potential of 0.34 V 
vs Ag/Ag+ and a peak potential of 0.94 V vs Ag/Ag+ for DBAE oxidation are observed 
(Figure 2.5b). On the other hand, BPO reduction occurs at 0.50 V vs Ag/Ag+ with a peak 
reduction potential of -1.60 V vs Ag/Ag+ (Figure 2.5c). The irreversible CV behavior of 
all three coreactants is consistent with the fact that the newly generated chemical species 
at the electrode underdoes immediately a series of chemical reactions in the solution so 
that no electroactive species remain when the electrode potential is scanned on the 
reverse direction.112  
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Figure 2.5 CVs of individual ECL coreactants. 
Note: CVs of (a) 25.0 mM TPrA, (b) 25.0 mM DBAE, and (c) 10.0 mM BPO in MeCN containing 0.10 M TBAP at a 2-mm Pt 
electrode with a scan rate of 100 mV/s. 
Electrode material can affect the redox behavior of coreactant, which is directly 
correlated to the ECL generation of a coreactant ECL system. Generally, the more 
coreactant reacts at the electrode, the more intermediates needed for ECL production are 
formed, thus the stronger the ECL intensity will be. Figure 2.6 shows the CVs of BPO at 
Pt, Au, and GCE. It is clear that in MeCN, Pt is the most favorable working electrode for 
BPO reduction, followed by Au electrode and then GCE. Previously, Pt has been shown 
to play a catalytic role towards many electrochemical processes.231-237  
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Figure 2.6 CVs of 10.0 mM BPO at different electrodes. 
Note: All CVs were carried out in MeCN containing 10.0 mM BPO-0.10 M TBAP at a 2-mm Pt electrode with a scan rate of 100 
mV/s. The solution was degassed for about 7 minutes with N2. 
Initial ECL tests were conducted in a mixture solution of DPA, RUB, and 
Ru(bpy)3
2+ using different ECL coreactants with linear sweep voltammetry. As shown in 
Figure 2.7, not detectable, weak, and strong ECL spectra are observed when ECL 
coreactant of TPrA (Figure 2.7a), DBAE (Figure 2.7b), and BPO (Figure 2.7c) are used, 
respectively. Clearly, neither TPrA nor DBAE is a suitable common coreactant for the 
mixture ECL system. This observation can be explained by the ECL mechanism.72 To 
generate ECL from an ECL emitter DPA (or RUB), electrochemically oxidized DPA•+ 
(or RUB•+) cation must annihilate with its DPA•– (or RUB•–) anion to form an excited 
state DPA* (or RUB*) that emits light. Because the redox potential of TPrA• free radical, 
i.e., -1.7 V vs SCE,223 is less negative than that of -2.24 V for the DPA/DPA•– couple or -
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1.79 V vs SCE for the RUB/RUB•– couple (Table 2.1), no significant amount of DPA•– 
(or RUB•–) anion is expected to produce. As a result, no or very weak ECL can be 
generated. The redox potential of DBAE• free radical is not available in the literature; it is 
estimated to be around -2.2 V vs SCE, because weak ECL responses are seen in the ECL 
emission regions of the DPA/DBAE (~420 nm) and RUB/DBAE (~550 nm) systems 
(Figure 2.7b). Note that TPrA• and DBAE• free radicals are produced after the 
electrochemical oxidation of TPrA and DBAE and subsequent deprotonation reaction, 
respectively.72 The above discussion, however, cannot be extended to the Ru(bpy)3
2+ 
case, as this system follows different ECL mechanisms.72 
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Figure 2.7 ECL spectra obtained from a mixture of DPA, RUB, and Ru(bpy)32+.  
Note: ECL spectra were obtained from a mixture of DPA (250.0 µM), RUB (25.0 µM), and Ru(bpy)3
2+ (25.0 μM) in MeCN 
containing 0.10 M TBAP with (a) 25.0 mM TPrA, (b) 25.0 mM DBAE, and (c) 10 mM BPO upon a linear potential sweep from 0 and 
2.0 V for (a) and (b) or 0 and -3.0 V vs Ag/Ag+ for (c) at a 2-mm diameter Pt electrode at a scan rate of 100 mV/s. The solution was 
degassed for about 7 min with N2 before ECL spectra were recorded.  
In contrast, when the cathodic ECL coreactant BPO is used, remarkably strong 
ECL emissions are observed for all the three ECL emitters (Figure 2.7c). Notably, 
emission spectra from RUB (~550 nm) and Ru(bpy)3
2+ (~620 nm) are overlapped, which 
can be deconvoluted as will be demonstrated later. Scheme 2.1 summarizes the ECL 
mechanism of the R/BPO system (R = DPA, RUB, or Ru(bpy)3
2+) involving both the 
energy-sufficient S-route and the energy-deficient T-route (Section 1.2.1 in Chapter I).72  
Briefly, upon the cathodic potential scanning, both BPO and ECL emitter R are 
electrochemically reduced to form BPO•– and R•– (Equations 2-1 and 2-2), and the former 
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further decomposes to produce a strong oxidizing intermediate, namely benzoate radical 
C6H5CO2
• (Equation 2.4), with a redox potential value of > +1.5 V vs SCE.238 This is 
followed by redox reactions between C6H5CO2
• and R (Equation 2.5) as well as R•– 
(Equation 2.6) to produce species (e.g., R•+, 1R*, and 3R*) necessary for ECL generation.  
BPO +  e →  BPO•−         (2.1)  
R +  e →  R•−         (2.2) 
R•− +  BPO →  R +  BPO•−         (2.3) 
BPO•−  →  C6H5CO2
−  + C6H5CO2
•
       (2.4) 
R +  C6H5CO2
•  →  R•+  + C6H5CO2
−       (2.5) 
R•−  +  C6H5CO2
•  →  R1 ∗  +  C6H5CO2
−        (2.6) 
R•−  +  C6H5CO2
•  →  R3 ∗  +  C6H5CO2
−
       (2.7) 
R3 ∗  +  R3 ∗  →  R1 ∗  +  R         (2.8) 
R3 ∗  +  BPO →  R•+  +  BPO•−        (2.9) 
R3 ∗  + C6H5CO2
•  →  R•+  +  C6H5CO2
−
       (2.10) 
R•−  +  R•+   →  R1 ∗  +  R        (2.11) 
R1 ∗  →  R +  hv         (2.12) 
(R = aromatic hydrocarbons such as DPA or RUB and Ru(bpy)3
2+). 
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Scheme 2.1  ECL mechanism with BPO as cathodic ECL coreactant. 
 
Effect of electrode material on ECL production of the R/BPO system was 
examined with the spectral ECL instrument. As shown in Figure 2.8, under the same 
experiemntal conditions, among the three tested working electrodes (Pt, Au, and GCE), 
Pt electrode produces the strongest ECL spectra for all three ECL emitters (Figure 2.8a), 
whereas GCE only gives weak ECL responses (Figure 2.8c). The ECL intensity obtained 
from Pt, Au, and GCE has an approximate ratio of 2.8/1.8/1 for Ru(bpy)3
2+, 3.8/1.9/1 for 
RUB, and 3.7/2.2/1 for DPA, respectively. These findings are consistent with the CV data 
shown in Figure 2.6, suggesting that the electrochemical reduction of BPO is a 
determining step for the ECL generation of the R/BPO system. In addition, at Pt 
electrode, the Ru(bpy)3
2+/BPO system produces nearly the same intense ECL as the 
RUB/BPO system does, which is about 20% stronger than that from the DPA/BPO 
system (Figure 2.8a).  
Based on the above discussion, it is concluded that the combination of BPO 
coreactant with Pt working electrode is the most favorable choice for ECL detection of a 
mixture of DPA, RUB, and Ru(bpy)3
2+ emitters.  
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Figure 2.8 Effect of electrode material on ECL intensity. 
Note: Plot of changes in ECL intensity per unit area vs a fixed concentration of ECL emitters (i.e., 25.0 µM) using 10.0 mM 
coreactant BPO (optimized concentration) in 0.10 M TBAP MeCN with a linear potential sweep from 0 to -3.0 V vs Ag/Ag+ at a scan 
rate of 100 mV/s. Hamamatsu mini-spectrometer was used to collect ECL spectra. 
2.3.3 Validation of the spectral ECL instrument 
The performance of the newly constructed mini-spectrometer based spectral ECL 
instrument was compared and validated with a homemade ECL setup that used a 
photomultiplier tube (PMT) as a light detector.239 Due to its extremely high sensitivity, 
the PMT based ECL instrument can detect ultra-low ECL emissions. Consequently, the 
ECL responses of all the three coreactants (i.e., TPrA, DBAE, and BPO) coupled with the 
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three ECL emitters (i.e., DPA, RUB, and Ru(bpy)3
2+) were recorded. Figure 2.9 shows 
such results, where BPO yields the most efficient ECL intensities for all the three ECL 
emitters, with a slightly less ECL intensity over the entire coreactant concentration range 
from the DPA/BPO system as compared with the RUB/BPO or Ru(bpy)3
2+/BPO system. 
Also, maximum ECL intensities appear at 10.0 mM BPO, which likely is explained by 
the two opposing roles of BPO has during the ECL generation (Scheme 2.1). On the one 
hand, BPO is needed for the production of BPO•−, C6H5CO2
•, R•+, 1R*, and 3R*, which is 
favorable to ECL generation. On the other hand, hoverer, BPO can react with the 
electrogenerated R•− (Equation 2.3), which reduces the chance of the ion annihilation 
reaction of R•+ + R•− → R* (Equation 2.11) and diminishes ECL generation. Significantly 
weak ECL responses are seen from the systems using TPrA or DBAE as an ECL 
coreactant, especially when DPA or RUB is used as an ECL emitter. As discussed earlier, 
the insufficient reducing capacity of TPrA• and DBAE• free radicals towards chemical 
reductions of DPA and RUB is probably the cause of such weak ECL emissions.  
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Figure 2.9 ECL responses of various coreactant ECL systems measured with a PMT 
based ECL instrument. 
Note: Integrated ECL-intensities of three different ECL emitters (i.e., RUB, Ru(bpy)3
2+, and DPA, 25.0 μM each) were plotted against 
various concentrations of three different co-reactants (i.e., BPO, DBAE, and TPrA). CV potential scanning between 0 and 2.0 V for 
TPrA and DBAE or 0 and -3.0 V vs Ag/Ag+ for BPO in 0.10 M TBAP MeCN at a 2-mm Pt electrode with a scan rate of 100 mV/s 
was used. The solution was degassed for about 7 min with N2 before ECL measurement was taken place. 
It is evident that the data shown in Figure 2.9 are consistent with the data shown 
in Figures 2.7 and 2.8, verifying that the constructed mini-spectrometer based spectral 
ECL instrument performed well.  
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2.3.4 Study of unmixed systems of ECL emitters 
Figure 2.10 shows the ECL spectra of individual ECL emitter DPA (Figure 
2.10A), RUB (Figure 2.10B), and Ru(bpy)3
2+ (Figure 2.10C) at various concentrations 
when 10.0 mM BPO is used as the cathodic ECL coreactant, with a maximum ECL 
emission at ~420 nm, ~545 nm, and 630 nm, respectively. These ECL peak values are in 
good agreement with those reported previously from ion annihilation reactions (Table 
2.1) as well as with fluorescence spectra displayed as an inset of the respective ECL 
spectra (Figures 2.10A-C). An excellent linear relationship between the ECL emitter 
concentration and the ECL peak intensity is shown in Figure 2.10D. Such a calibration 
curve is useful for quantifying target analyte when the R/BPO system is used for ECL 
based single or multiplexed assays. 
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Figure 2.10 ECL spectra of (A) DPA, (B) RUB, and (C) Ru(bpy)32+ at various 
concentrations using BPO as coreactant. (D) Relationship between the emitter 
concentration and ECL peak intensity. 
Note: All ECL measurements were carried out with the spectral ECL instrument in 0.10 M TBAP MeCN solution containing 10.0 mM 
BPO and various concentrations of ECL emitter after degassed with N2 for 7 min at a 2-mm diameter Pt electrode over a linear 
potential sweep from 0 to -3.0 V vs Ag/Ag+ at 100 mV/s. Insets in (A)-(C) were comparisons between ECL and fluorescence spectra. 
For fluorescence experiments carried out with a PTI Qunata Master 40TM intensity based spectrofluoromter, 2.50 µM of each ECL 
emitter in MeCN was used. The excitation wavelength for DPA, RUB, and Ru(bpy)3
2+ was 370 nm, 490 nm, and 450 nm, respectively. 
These wavelengths were the maximum absorption peak wavelengths of the emitters measured with a Beckman Coulter DU 800 
UV/Vis spectrophotometers. 
2.3.5 Study of binary mixed systems of ECL emitters 
Among DPA, RUB, and Ru(bpy)3
2+ ECL emitters, three binary combinations of 
them, namely, DPA-RUB, DPA-Ru(bpy)3
2+, and RUB- Ru(bpy)3
2+, were studies. Figure 
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2.11 shows the ECL spectra of the (DPA-RUB)/BPO system with a constant 
concentration of RUB (25.0 M) mixed with different concentrations of DPA. With the 
increase of DPA concentration, ECL intensity at ~420 nm for DPA emissions increases 
as expected. Meanwhile, the ECL intensity at ~540 nm for RUB emissions also increases 
slightly. The inset in Figure 2.11 displays the linear responses of ECL intensities with the 
concentration of DPA. The increase in RUB ECL with the increase of [DPA] can be 
contributed to the energy transfer between DPA* and RUB as DPA* + RUB  RUB*.  
This explanation is supported by the fluorescence spectra of DPA and the absorption 
spectra of RUB (Figure 2.12), where partially overlap of the two spectra is evident. 
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Figure 2.11 ECL spectra of the (DPA-RUB)/BPO system with a constant concentration 
of RUB mixed with various concentrations of DPA.  
Note: [DPA] was increased from 50.0 µM to 250 µM while [RUB] at 25.0 µM was held constant with 10.0 mM BPO as ECL 
coreactant. All ECL measurements were carried out using the spectral ECL instrument in MeCN solution containing 0.10 M TBAP 
supporting electrolyte after degassed with N2 for 7 min at a 2-mm diameter Pt electrode with at a CV scan rate of 100 mV/s.  
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Figure 2.12 Fluorescence spectra of DPA and absorption spectrum of RUB. 
Note: The experiments were carried out in MeCN. The slit width was 0.75 mm. The excitation wavelength for florescence experiment 
was 370 nm. 
The ECL behavior of the (DPA-Ru(bpy)3
2+/BPO system is shown in Figure 2.13. 
Under a constant [DPA], the ECL intensity for Ru(bpy)3
2+ emissions at ~630 nm 
increases with the increase of [Ru(bpy)3
2+], whereas the ECL signal for DPA emissions at 
~420 nm decreases (Figure 2.13A). On the other hand, under a constant [Ru(bpy)3
2+], the 
ECL intensity of DPA as well as Ru(bpy)3
2+ increases with the increase of [DPA] (Figure 
2.13B), although in the latter case, the ECL intensity change is insignificant. These data 
can be explained with the energy transfer between DPA* and Ru(bpy)3
2+ through a 
reaction process of DPA* + Ru(bpy)3
2+  Ru(bpy)32+*, as illustrated by the partial 
overlapping of the fluorescence spectra of DPA and the absorption spectra of Ru(bpy)3
2+ 
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(Figure 2.14). Fluorescence titration experiments of DPA with Ru(bpy)3
2+ (Figure 2.15) 
further support the above explanation.   
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Figure 2.13 ECL spectra of the (DPA-Ru(bpy)32+)/BPO system with a constant 
concentration of (A) DPA and (B) Ru(bpy)3
2+ mixed with various concentrations of (A) 
Ru(bpy)3
2+ and (B) DPA.  
Note: (A) [Ru(bpy)3
2+] was increased from 25.0 µM to 125.0 µM while [DPA] at 200.0 µM was held constant, and (B) [DPA] was 
increased from 200.0 µM to 400.0 µM while [Ru(bpy)3
2+] at 10.0 µM was held constant with 10.0 mM BPO as ECL coreactant. All 
ECL measurements were carried out using the spectral ECL instrument in MeCN solution containing 0.10 M TBAP supporting 
electrolyte after degassed with N2 for 7 min at a 2-mm diameter Pt electrode with at a CV scan rate of 100 mV/s.  
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Figure 2.14 Fluorescence spectra of DPA and absorption spectra of Ru(bpy)32+. 
Note: The experiments were carried out in MeCN. The excitation wavelength for DPA emission was 370 nm. 
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Figure 2.15 Fluorescence spectra of DPA with the addition of various amounts of 
Ru(bpy)3
2+. 
Note: [DPA] was fixed at 2.5 µM whereas [Ru(bpy)3
2+] was gradually allowed to increase from 2.5 µM till 20 µM. The fluorescence 
titration experiments were carried out in MeCN. The excitation wavelength was 370 nm and the slit width was 0.75 mm. 
Finally, the ECL properties of the (RUB-Ru(bpy)3
2+)/BPO system were 
investigated. Because the peak values of these two ECL emitters are relatively close (540 
vs 630 nm) and their individual spectra are broad, experimentally obtained overall ECL 
spectra as shown in Figure 2.16 are significantly overlapped.  To resolve the peak 
overlapping, “multiple peak fit” function within OriginLab software was used. 
Specifically, two “biguanssian” peak functions with one peak located at ~540 nm for 
RUB and the other at ~630 nm for Ru(bpy)3
2+ were initialized. The calculated best 
overall fitting curve (solid line) was found to match well with the experimental data 
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(Figure 2.16), where individual ECL spectra for each emitter (dashed lines) were also 
displayed. As a result, the respective ECL intensity of RUB and Ru(bpy)3
2+ in the binary 
system can be estimated. Note that such a spectral simulation or fitting is constrained by 
the known ECL emissions including λmax values. Therefore, errors introduced by 
deconvolution of experimentally obtained spectra are small. Spectral fitting of severely 
overlapped peaks in high resolution X-ray photoelectron spectroscopy has been widely 
used for many years.240 Figure 2.16A shows that the ECL intensity of RUB increases 
with the increase of its concentration and the ECL for Ru(bpy)3
2+ remains unchanged 
when a constant [Ru(bpy)3
2+] is used. The opposite is also true. As shown in Figure 
2.16B, when [RUB] remains constant, the ECL intensity of Ru(bpy)3
2+ increases with the 
increase of [Ru(bpy)3
2+], and the ECL of RUB is not influenced by the addition of RUB. 
These data suggest that, unlike in the cases involving DPA (Figures 2.11 and 12), no 
energy transfer between RUB and Ru(bpy)3
2+ exists. This is not surprising because the 
energy difference between the two excited ECL emitters is rather close. 
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Figure 2.16 ECL spectra of the (RUB-Ru(bpy)32+)/BPO system with a constant 
concentration of (A) Ru(bpy)3
2+ and (B) RUB mixed with various concentrations of (A) 
RUB and (B) Ru(bpy)3
2+.  
Note: (A) [RUB] was increased from 25.0 µM to 125.0 µM while [Ru(bpy)3
2+] at 25.0 µM was held constant, and (B) [Ru(bpy)3
2+] 
was increased from 25.0 µM to 125.0 µM while [RUB] at 25.0 µM was held constant with 10.0 mM BPO as ECL coreactant. All ECL 
measurements were carried out using the spectral ECL instrument in MeCN solution containing 0.10 M TBAP supporting electrolyte 
after degassed with N2 for 7 min at a 2-mm diameter Pt electrode with at a CV scan rate of 100 mV/s.  
2.3.6 Study of ternary mixed systems of ECL emitters 
In this section, ECL behavior of ternary mixed systems of (DPA-RUB-
Ru(bpy)3
2+/BPO is presented. Figure 2.17 shows a typical ECL spectra obtained from a 
mixture of DPA, RUB, and Ru(bpy)3
2+ using BPO as the cathodic coreactant. The peak at 
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~420 nm for DPA emission is well separated from the overlapped broad peak at ~600 nm 
for emissions from RUB and Ru(bpy)3
2+. Using the same strategy for the deconvolution 
of mixed ECL spectra of RUB and Ru(bpy)3
2+ (Figure 2.16 in Section 2.3.5), this ternary 
ECL spectra can be also well resolved with the “multiple peak fit” function in OriginLab 
as demonstrated in Figure 2.17. Consequently, ECL intensities of respective individual 
emitters can be estimated.   
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Figure 2.17 Deconvolution of ECL spectra obtained from a mixture of DPA, RUB, and 
Ru(bpy)3
2+.  
Note: ECL spectra were obtained from a mixture of DPA (250.0 µM), RUB (25.0 µM), and Ru(bpy)3
2+ (25.0 μM) in MeCN 
containing 10.0 mM BPO-0.10 M TBAP at a 2-mm diameter Pt electrode with a scan rate of 100 mV/s. The solution was degassed for 
~7 minutes with pure nitrogen gas. 
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Figure 2.18 shows three examples of the ECL responses from ternary mixed 
systems of ECL emitters. In each case, concentrations of two of the three ECL emitters 
remain unchanged, and the ECL intensity of each emitter is examined along with the 
concentration change of the third emitter. Specifically, the effect of [DPA], [RUB], and 
[Ru(bpy)3
2+] on the overall ECL behavior is revealed in Figures 2.18A, B, and C, 
respectively. Detailed linear relationship between the individual ECL intensity and the 
third ECL emitter concentration is plotted and placed aside of the ECL spectra as an 
inset. These data can be explained using the energy transfer between the high energy 
excited DPA* species and the ground state RUB or Ru(bpy)3
2+ to form a relatively low 
energy excited state species of RUB* or Ru(bpy)3
2+*.  
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Figure 2.18 ECL spectra of the (DPA-RUB- Ru(bpy)32+)/BPO system with the 
concentration change of (A) DPA, (B) RUB, and (C) Ru(bpy)3
2+ while two other ECL 
emitter concentrations remained unchanged. 
Note: Experiments were carried out in MeCN solution containing 10.0 mM BPO-0.10 M TBAP after degassed with N2 for ~7 min at a 
2-mm diameter Pt electrode with a CV scan rate of 100 mV/s.  
Although energy transfer related interactions between ECL emitters were 
observed, which seems to make the proposed three ECL emitters a bit unfit for potential 
use in ECL based multiplexed assays, it is expected that this kind of interaction should 
become negligible at a lower concentration range (e.g., sub-micromolar or below) that is 
often the case in real sample analysis. 
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2.4 Hazards 
Polycyclic aromatic hydrocarbons (PAHs) have carcinogenic effects. Acute 
(short-term) inhalation of acetonitrile exposure results in irritation of mucous membranes 
whereas its chronic (long-term) exposure results in central nervous system effects, such 
as headaches, numbness, and tremors. TPrA and DBAE are skin and eye irritants and the 
solutions of these must be prepared under hood. BPO can be explosive if exposed to heat, 
shock or friction. 
2.5 Conclusion 
An inexpensive and portable spectral ECL instrument was constructed. This setup 
consisted of a portable “WaveNow” potentiostat from Pine Research Instrumentation and 
a Hamamatsu mini-spectrometer, and was capable of conducting regular electrochemical 
experiments and measuring ECL spectra. The newly homemade instrument was used to 
study the cyclic voltammetry of individual ECL emitters (i.e., DPA, RUB, and 
Ru(bpy)3
2+) and coreactants (i.e., TPrA, DBAE, and BPO) as well as the ECL behavior of 
various combinations of ECL emitter-coreactant at different working electrodes (i.e., Pt, 
Au, and GCE). The results from ECL titration studies of unmixed and mixed systems of 
ECL emitters using the most efficient cathodic BPO coreactant at Pt electrode provided 
fundamental data for ECL spectral based multiplexing detection of analytes. Certain 
interactions between co-existing ECL emitters were explained with the energy transfer 
from a high energy excited stated emitter to another relatively low energy ground state 
emitter, which was supported by the fluorescence and absorption spectroscopic data.   
Finally, the experimentally obtained overlapping ECL spectra were well resolved with 
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the “multiple peak fit” function of OriginLab program. Parts of the experiments reported 
in this chapter were carried out with the integrated homemade spectral ECL instrument 
can be well-adapted to various levels of analytical chemistry or instrumental analysis 
teaching laboratories. 
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CHAPTER III - SYNTHESIS, ELECTROCHEMISTRY AND ECL STUDIES OF 
WATER SOLUBLE ANALOGUES OF 9,10-DIPHENYLANTHRACENE AND 
RUBRENE WITH NITRATE AS ECL ENHANCING AGENT  
3.1 Introduction 
The sensitive ECL detection of biomolecules is highly desirable if the efficient 
ECL emitters are soluble in water so that ECL immunoassay can be performed in 
aqueous buffer media. This is because aqueous media generally is considered to be safer, 
greener, and more ecofriendly than organic solvents. Also, organic media are not 
compatible with commercial ECL instruments. Moreover, most in-vitro and in-vivo 
studies are performed in aqueous buffer conditions. Among the three studied ECL 
emitters in Chapter II, 9,10-diphenylanthracene (DPA) and rubrene (RUB) are water 
insoluble, whereas Ru(bpy)3Cl2
 is soluble in both aqueous and organic media. A wide 
range of publications on ECL detection in aqueous media utilize Ru(bpy)3
2+ and its 
derivatives241-253 as well as quantum dots (QDs)254-267 as ECL labels. However, there has 
been no any report on usage of water soluble derivatives of efficient ECL emitters of 
DPA and RUB for ECL detection purposes in aqueous systems. Thus, it is important to 
synthesize their water-soluble derivatives so that all the three emitters could be used for 
spectral separation based multiplexing detection of analytes in aqueous media. 
Previously,268,269 9,10-diphenylanthracene-2-sulfonate has been shown to produce weak 
ECL with anodic coreactant tri-n-propylamine (TPrA) and cathodic coreactant persulfate 
in acetonitrile–water (1:1 v/v) mixture media. 
This chapter presents the synthesis, electrochemistry and anodic coreactant (i.e., 
TPrA and 2-(dibultylamino)ethanol (DBAE)) ECL studies of water soluble sulfonated 
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9,10-diphenylanthracene (DPAS) and sulfonated rubrene (SRUB). ECL enhancement 
with nitrate was demonstrated. The direct electron paramagnetic resonance (EPR) 
spectroscopic evidence of nitrate radical was obtained, which further supported the 
proposed ECL enhancement mechanism.  
3.2 Experimental Section 
3.2.1 Chemicals 
Rubrene (RUB, ≥99%), tri-n- propylamine (TPrA, 99+%), 2-
(dibutylamino)ethanol (DBAE, 99%), sodium phosphate monobasic monohydrate 
(NaH2PO4 • H2O, 99%), nitrobenzene, potassium nitrate (KNO3, 98%), lithium nitrate 
(KNO3, 98%), CDCl3 (chloroform-d, 99.6% atoms D and 0.3%  v/v TMS) and 
hydrochloric acid (HCl, 37.5%) were obtained from Sigma-Aldrich. Fuming sulfuric acid 
was from Acros Organics. Dioxane, methylene dichloride, and ethylene dichloride were 
purchased from Thermo Fisher Scientific. Acetonitrile (MeCN, 99.93+%, HPLC grade) 
was from MP Biomedicals. Sodium nitrate (NaNO3) and ammonium nitrate (NH4NO3) 
were purchased from Baker Chemical Co. Methanol (spectroanalyzed grade) and 9,10-
diphenylanthracene (DPA, 98%) were obtained from Fluka. 2,2-diphenyl-1-
picrylhydrazyl 5,5-dimethyl-1-pyrroline N-oxide (DMPO) was received from Cayman 
Chemical. All chemicals were used as received, unless otherwise stated.  
3.2.2 Apparatus and methods 
All electrochemical and ECL experiments were performed with a CHI 660A 
electrochemical workstation (CH Instruments, Austin, TX) coupled with a 
photomultiplier tube (PMT) (Hamamatsu R928, Japan) installed in a light tight black box 
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as shown in Figure 3.1. To prevent from external background light interferences, the 
electrochemical cell with testing solution was placed inside the light tight box that 
covered with a black blanket.113,270 To supply a voltage of -700 V to the PMT, a model 
472A Brandenburg PMT power supply (England) was used. A highly sensitive Keithley 
6514 electrometer (Keithley, Cleveland, OH) was used to detect the photocurrent from 
the testing sample and converts to voltage (± 2.0 V). 
 
Figure 3.1 Homemade ECL instrument setup. 
Note: The ECL setup consists of (A) potentiostat, (B) PMT, (C) light tight box with PMT installed, (D) PMT power supply, and (E) 
electrometer. 
For recording ECL spectra, a workstation from Princeton Instrument (Acton, MA) 
comprising (A) a Spec-10:400B/LN-eXcelon digital charge coupled device (CCD) 
camera system cooled to -120 °C with liquid nitrogen, (B) ST 133B controller, and (C) 
Acton SP-2156 imaging spectrograph was used. The system was controlled and data were 
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collected and displayed via “WinSpec/32” software. Electrochemical and ECL signals 
were generated with a model 173 potentiostat/galvanostat coupled with a model 175 
universal programmer from Princeton Applied Research (Oak Ridge, TN). ECL 
emissions at the Pt working electrode were carried over by an optical fiber to the CCD 
detector through a 1.5 mm slit. Figure 3.2 shows a photograph of the above CCD based 
ECL spectral instrument. 
 
Figure 3.2 Liquid nitrogen cooled CCD camera-based ECL spectral instrument setup. 
Note: The setup consists of (A) CCD Camera, (B) monochromator, (C) CCD camera controller, (D) three-electrode electrochemical 
cell, (E) light tight black box, (F) computer, and (G) potentiostat/galvanostat. 
Diamond crystal attenuated total reflection Fourier transform infrared (ATR-
FTIR) experiments were performed with a Nicolet Nexus 470 FTIR spectrometer 
(Thermo Electron Corp., Madison, WI.). A pinch of crystalline precursors (RUB and 
DPA) and synthesized dried solid products (DPAS and SRUB) were used to collect FTIR 
spectra. 
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1H NMR spectroscopic experiments were performed using Bruker 400 MHz 
NMR spectrometer using a concentration of 5.0 mg/mL in CDCl3. 
Mass spectrometry experiments were performed on a Thermo-Finnigan LXQ 
electro-spray ionization (ESI)-ion trap mass spectrometer using negative ion mode with a 
concentration of 0.1 mg/mL and a flow rate of 100 µL/min in MeCN/H2O (50:50, v/v) 
mixed solvent systems. 
Electron paramagnetic resonance (EPR) spectroscopy was performed with a 
Bruker EMX microX EPR spectrometer equipped with an ER 4119HS standard 
cylindrical resonator (Bruker BioSpin Corp.). A resonant frequency of 19.89 GHz, a 
modulation frequency of 100 kHz, and a microwave power of 20 mW were used. Pre-
calibration of the EPR instrument was done using the manufacturer’s 2,2-diphenyl-1-
picrylhydrazyl (DPPH), 1, 3-bis diphenylene-2-phenyl allyl (BDPA), and weak pitch 
standard calibration samples. Nitrate radicals (NO3
•) were produced in situ with UV 
irradiation from a Bruker illumination accessory using 0.10 M KNO3 in the presence of 
0.20 M DMPO spin trap agent in aqueous media. Experimentally, the mixture solution 
was filled into a standard glass capillary (10 cm long, 2/1.2 OD/ID (mm), World 
Precision Instruments, Inc., Sarasota, FL) to a height of ~4 cm and sealed with 
“permanent avery glue stic” (Office Depot, Hattiesburg, MS) at the bottom to prevent any 
leakage of the sample. This capillary was then placed in a regular quartz EPR tube 
(Wilmad Lab Glass) for spectra acquisition. The experimentally obtained EPR spectra 
were simulated using PEST Winsim Software (National Institute of Environmental 
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Health Sciences, National Institute of Health, Research Triangle Park, NC) for 
calculating hyperfine coupling constants. 
3.3 Synthesis 
3.3.1 Synthesis of water soluble analogue of DPA — Sodium-9,10-
diphenylanthracene sulfonate (SDPAS) 
DPAS was synthesized as reported in the literature269,271-273,274,275 with some 
modifications. Briefly, 1.00 g (3.0 mmol) of 9,10-diphenylanthracene (DPA) was 
dissolved in 7.0 mL nitrobenzene to form a clear yellow solution, to which excess fuming 
sulfuric acid (500.0 μL) was added slowly over a period of five minutes. The reaction 
was allowed to occur for 36 h under stirring before a volume of 200.0 mL water was 
added. The mixture was separated into two phases — the aqueous phase on the top and 
the organic phase on the bottom as nitrobenzene (specific density 1.20 g/mL) was heavier 
than water. The aqueous phase was separated from the organic phase with a separatory 
funnel, adjusted to pH 7.0 with 10.0 M NaOH, and heated to evaporate the solvent until 
~10 mL. 300.0 mL of methanol was subsequently added to the above concentrated 
aqueous phase that immediately turned into white slurry (i.e., unreacted DPA). The 
filtered methanol solution was concentrated by distillation, yielding ~0.35 g (or ~0.85 g 
in the second batch of synthesis) of crude sulfonated DPA (e.g., SDPAS, light yellow 
solid). 
The crude product was purified by ion-exchange column chromatography using 
Dowex 1×2-100 ion-exchange resin (50-100 dry mesh; 3×1 cm) and eluted with a 
gradient of 0 to 0.50 M HCl in methanol. Experimentally, the crude yellow product was 
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re-dissolved in 10.0 mL of methanol with stirring and sonication. The supernatant was 
applied to the ion-exchange column and eluted with (1) 5.0 mL methanol, (2) 5.0 mL of 
0.25 M HCl in methanol, and (3) 5.0 mL of 0.50 M HCl in methanol. Fractions from the 
last two elution steps were collected and placed in a refrigerator overnight. The 
precipitates were transferred to a glass petri dish covered with a piece of filter paper and 
air-dried for several days under ambient conditions. Finally, ~45 mg (~3% yield) of light 
yellow-green DPAS was scraped from the petri dish with a razor blade. Theoretically, 
~1.53 g of the final product should be obtained. The low yield in this synthesis could be 
due to (1) low efficiency of sulfonation reaction, and (2) the loss of the product during 
the ion-exchange purification process. In the latter case, it might be a good idea to collect 
all materials after vaporizing the fractions from the last two elution steps, because 
experimentally, no any precipitate was seen at 4 ºC from the fraction of pure methanol 
elution (i.e., the first elution step), indicating that the later fractions should essentially 
contain pure products. Scheme 3.1 illustrates the synthesis of SDPAS.  
 
Scheme 3.1 Synthesis of SDPAS using the sulfonation of DPA. 
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3.3.2 Synthesis of water soluble sulfonated rubrene (SRUB) 
SRUB was synthesized as reported in the literature127,276 with some modifications. 
Briefly, 1.00 g of rubrene (RUB, 1.8 mmol) was dissolved in a mixed solvent system 
consisting of 80.0 mL of 1,4-dioxane, 80.0 mL of ethylene dichloride, and 40.0 mL of 
methylene dichloride (2:2:1 in v/v) to form a clear red solution. Excess fuming sulfuric 
acid (500.0 μL) was added to the above solution slowly over a period of five minutes. 
The reaction media was stirred for 36 h followed by adding 200.0 mL of water into the 
mixture, which produced two separate phases with aqueous phase containing the product 
on the top and the organic layer on the bottom due to density difference. The aqueous 
layer was then collected with a separatory funnel and neutralized with 10.0 M NaOH. 
Solution evaporation via heating was undertaken until ~10 mL of concentrated solution 
was obtained. Subsequently, 300.0 mL of methanol was added, turning the solution to be 
white slurry. The filtered methanol solution was finally concentrated by distillation, 
yielding 180.0 mg of SRUB product (light red crystalline, ~13.04% yield). The synthetic 
steps are outlined in Scheme 3.2. 
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Scheme 3.2 Synthesis of SRUB using the sulfonation of RUB. 
 
3.4 Results and Discussion 
3.4.1 Structural characterization and elucidation 
Figure 3.3 shows the Fourier transform infrared (FTIR) spectra of pure precursors 
(DPA and RUB) along with their sulfonated products (DPAS and SRUB). The IR peaks 
between 1000-1400 cm-1 correspond to sulfur-oxygen stretching vibrations. More 
specifically, the IR bands at positions ~1156 cm–1, ~1127 cm–1, ~1040 cm–1, and ~1006 
cm–1 all account for the -SO3 stretching vibrations of the sulfonate group
277-280 from the 
sulfonated products, providing solid proof of sulfonation during the synthesis of DPAS 
(Figure 3.3 A) and SRUB (Figure 3.3B). The band at ~1400 cm-1 is due to the symmetric 
and asymmetric stretching vibrations of O=S=O of the sulfonate group of the sulfonated 
products.280 The broad peak between 3000-3500 cm-1 in Figures 3.3A and B account for 
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the -OH stretching, possibly from a trace amount of water or MeOH used in the synthetic 
steps. The shoulder just above 3000 cm-1 in both the Figures 3.3A and B was assigned for 
Ar-H stretching both the precursors and the sulfonated products containing benzene 
moieties (for instance DPA and DPAS contain 5 benzene rings while RUB and SRUB 
contains 8 benzene rings). 
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Figure 3.3 FTIR spectra of (A) DPA and DPAS, and (B) RUB and SRUB. 
Note: The arrows marked are signature bands for -SO2 and SO3 stretching vibrations. 
The evidence of successful sulfonation of DPA is also witnessed by electro-spray 
ionization mass spectrometry (ESI-MS) (Figure 3.4), where the m/z peak at 409 in 
negative mode scan corresponds to the molecular mass of DPAS having molecular mass 
of its precursor DPA plus one sulfonated group. Moreover, no ESI-MS peak for the 
precursor DPA (molecular weight = 330.45 g/mol) was seen, suggesting the high purity 
of the final DPAS product.  
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Figure 3.4 ESI-MS data of DPAS. 
The ESI-MS data were obtained with 0.1 mg/mL DPAS in MeCN: H2O (50:50, v/v) at a flow rate of 100 µL/min in negative mode 
scan. 
Proton nuclear magnetic resonance (1H-NMR) spectroscopy data (Figure 3.5A) 
revealed a total of 18 protons upon integration when the precursor DPA was subjected to 
1H-NMR spectroscopy (molecular formula of DPA = C22H18). On the other hand, the 
integration of the 1H-NMR of sulfonated DPAS data showed a total of 17 protons (Figure 
3.5B), indicating that DPAS (molecular formula = C22H17SO3H) contains only one 
sulfonated group. This finding is consistent with the MS data described above. Similarly, 
the integration of all the NMR peaks from 1H -NMR data of rubrene (RUB) (molecular 
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formula = C42H28) summed to a total of 28 protons (Figure 3.5C). On the other hand, the 
1H-NMR sulfonated rubrene (SRUB) data upon integration of all NMR peaks gave a total 
of 26 protons (Figure 3.5D), confirming that 2 protons were replaced by two sulfonated 
groups resulting in the synthesis of disubstituted sulfonated rubrene, i.e. the final product 
SRUB (molecular formula = C42H26S2O6H2). 
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Figure 3.5 1H-NMR spectroscopy data of (A) DPA, and (B) DPAS, (C) RUB, and (D) 
SRUB. 
Note: 1H-NMR spectroscopy experiments were performed with a concentration 5 mg/mL in CDCl3. 
3.4.2 Electrochemistry of DPAS and SRUB 
The solubility of sulfonated DPA (DPAS) and sulfonated rubrene (SRUB) was 
very low (~10 µM) in sodium phosphate buffer (PBS, pH 7.5). To acquire good CV 
signals, DPAS and SRUB were dissolved in 95% PBS (pH 7.5)-5% MeCN (v/v) with an 
estimated concentration of 50 µM (saturated). As shown in Figure 3.6A, DPAS 
irreversibly oxidizes at ~1.17 V vs Ag/AgCl (3.0 M KCl) at a glassy carbon electrode 
(GCE), indicating that the DPAS radical cation is not sufficiently stable in the reaction 
D 
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media within the time scale of the experiment. To better probe the electrochemical 
behavior of DPAS, differential pulse voltammetry (DPV) was applied, in which, DPAS 
oxidizes with a peak potential of 1.07 V vs Ag/AgCl (Figure 3.6B). The pre-wave 
appeared in DPV could result from the adsorption of DPAS on GCE.  
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Figure 3.6 (A) CVs, and (B) DPVs of DPAS in aqueous media. 
Note: In Figure 3.6A, (a) CV of the background (0.10 M PBS (pH 7.5 with 5% MeCN (v/v)), (b) CV of ~50 μM DPAS in 0.10 M PBS 
(pH 7.5) with 5% MeCN (v/v), and (c) CV after background subtraction. In Figure 3.6B, (a) background (0.10 M PBS (pH 7.5 with 
5% MeCN (v/v)), (b) DPV of 50 μM DPAS in 0.10 M PBS (pH 7.5) with 5% MeCN (v/v). Both CV and DPV experiments were 
performed using a 3-mm GCE.at (A) a scan rate of 100 mV/s and (B) pulse width = 0.2 s, sample width = 0.016 s, and pulse period = 
0.5 s. 
Similarly, the irreversible oxidation of SRUB occurs at ~0.80 V vs Ag/AgCl on 
CV and ~0.86 V vs Ag/AgCl on DPV as shown in Figure 3.7A and Figure 3.7B, 
respectively. The oxidation potentials for sulfonated DPA and RUB are close to their 
predecessors as discussed in Table 2.1 of Chapter II, although different solvents and 
electrodes were used.  
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Figure 3.7 (A) CVs, and (B) DPVs of SRUB in aqueous media. 
Note: In Figure 3.7A, (a) CV of the background (0.10 M PBS (pH 7.5 with 5% MeCN (v/v)), (b) CV of ~50 μM SRUB in 0.10 M PBS 
(pH 7.5) with 5% MeCN (v/v), and (c) CV after background subtraction. In Figure 3.7B, (a) background (0.10 M PBS (pH 7.5 with 
5% MeCN (v/v)), (b) DPV of 50 μM SRUB in 0.10 M PBS (pH 7.5) with 5% MeCN (v/v). Both CV and DPV experiments were 
performed using a 3-mm GCE.at (A) a scan rate of 100 mV/s and (B) pulse width = 0.2 s, sample width = 0.016 s, and pulse period = 
0.5 s. 
3.4.3 Effect of ECL coreactant and electrode material on ECL production  
Various anodic and cathodic ECL coreactants were tested to find out the most 
suitable or favorable ECL coreactant for DAPS and SRUB. As only extremely weak ECL 
was observed from cathodic coreactant persulfate, the following discussion focuses on 
anodic ECL coreactants DBAE and TPrA. As shown in Figure 3.8, upon the anodic 
potential scanning, ECL is produced from the DPAS/DBAE system (Figure 3.8A) and the 
 88 
DPAS/TPrA system (Figure 3.8B) at all three tested electrodes, namely, Pt, Au, and 
glassy carbon (GC) electrode. 
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Figure 3.8 Effect of electrode material on the ECL intensity of (A) DPAS/DBAE and (B) 
DPAS/TPrA system. 
Note: ECL was generated with DPAS using (A) 25 mM DBAE and (B) 25 mM TPrA. The concentration of DPAS was 7.5 μM at 
different electrodes (indicted in the Figure) at a scan rate of 100 mV/s. 
Similar behavior was observed for the SRUB/DBAE system (Figure 3.9A) and 
the SRUB/TPrA system (Figure 3.9B).  
Several features are noticed: (1) ECL generated from DPAS occurs at a more 
positive potential than SRUB does, (2) for the same ECL emitter (DPAS or SRUB), 
much stronger ECL signals are produced when DBAE rather than TPrA is used as the 
coreactant, (3) relative weak ECL signals are produced from DPAS as compared with 
SRUB, and (4) electrode materials strongly affect the ECL behavior.       
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Figure 3.9 Effect of electrode material on the ECL intensity of (A) SRUB-DBAE and (B) 
SRUB-TPrA system.  
Note: ECL was generated with SRUB using (A) 25 mM DBAE, and (B) 25 mM TPrA. The concentration of SRUB was 7.5 μM at 
different electrodes (indicted in Figure) at a scan rate of 100 mV/s. 
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The striking features that summarize DPAS system are enlisted as: (1) ECL 
generated from DPAS occurs at a more positive potential than SRUB does, (2) for the 
same ECL emitter (DPAS or SRUB), much stronger ECL signals are produced when 
DBAE rather than TPrA is used as the coreactant, (3) relative weak ECL signals are 
produced from DPAS as compared with SRUB, and (4) electrode materials strongly 
affect the ECL behavior. These observations can be explained with the ECL mechanism 
shown in Scheme 3.3, where DBAE could be replaced with TPrA as both coreactants 
share the similar reaction pathways.30  
DBAE −  e →  DBAE•+  (electrochemical oxidation)   (3.1) 
R −  e →  R•+   (electrochemical oxidation)   (3.2) 
DBAE•+ − H+  →  DBAE•  (deprotonation)    (3.3) 
R•+  +  DBAE•  →  R∗  (chemical reduction)    (3.4) 
R +  DBAE•  →  R•−   (chemical reduction)    (3.5) 
R•+  +  R•−  →  R∗  +  R   (excited state formation)   (3.6) 
R∗  →  R +  hv   (ECL generation)     (3.7)  
(R = DPAS or SRUB, and DBAE = (CH3CH2CH2CH2)2NCH2CH2OH) 
Scheme 3.3 ECL mechanism with DBAE as an anodic ECL coreactant. 
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To generate ECL, both coreactant and ECL emitter must be electrochemically 
oxidized (Equations 3.1-3.2). Because the oxidation of coreactant often occurs at a less 
positive potential region than that of ECL emitter, the onset potential of ECL generation 
is essentially determined by the oxidation potential of the emitter. As discussed earlier in 
Figures 3.6 and 3.7, DPAS oxidizes at ~1.1 V vs Ag/AgCl but SRUB at ~0.8 V vs 
Ag/AgCl, it is expected that the ECL system of DPAS appears at a more positive 
potential region. The ECL-CV profiles shown in Figure 3.10 further supports the above 
discussion. In this Figure 3.10, 25 mM of DBAE and 7.5μM of DPAS are used, hence the 
CV responses should be predominated by the oxidation of DBAE. The ECL intensity is 
also directly proportional to the amount of the coreactant oxidized; the more coreactant 
oxidation is (Equation 3.1), the freer radicals of DBAE• (or TPrA•) forms (Equation 3.3), 
the more excited state species R* is produced (Equation 3.5), thus the stronger the ECL 
intensity (Equation 3.7). Electrochemical oxidation of DBAE has shown to be easier than 
that of TPrA (see Figure 2.5 in Chapter II for more details). As a result, the DBAE 
system gives stronger ECL signals than the TPrA system. To make Equation 3.5 occur, 
the reducing power of the free radical, i.e., the reduction potential of DBAE• (or TPrA•), 
must be more negative than that of R•−. As shown in Table 2.1 of Chapter II, DPA has a 
much negative reduction potential (-2.24 V vs SCE) than that of RUB (-1.79 V vs SCE) 
in MeCN, it is likely that the reduction potential of DPAS in aqueous solution is much 
negative than that of SRUB. In other words, the chance of Equation 3.5 to occur is more 
likely for SRUB as compared with DPAS. Therefore, SRUB displays stronger ECL than 
DPAS does. 
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Figure 3.10 ECL-CV profiles of the DPAS-DBAE system. 
Note: ECL-CV profiles were obtained with 7.5 µM DPAS-25 mM DBAE at a 2-mm Pt electrode sweeping at 100 mV/s in 0.10 M 
PBS (pH 7.5). 
Figures 3.11 shows the effect of coreactant concentration and electrode material 
on ECL intensity of the DPAS/DBAE system (Figures 3.11A and B) and the SRUB/TPrA 
system (Figure 3.11C and D). It is evident that for DBAE coreactant, the optimal 
concentration for both DPAS and SRUB ECL production is around 25 mM (Figures 
3.11A and C).  This could be because DBAE acts as both ECL coreactant and ECL 
quencher. For TPrA, however, the higher the concentration is, the higher the ECL signal 
is generated (Figures 3.11B and D). This is consistent with the fact that the higher the 
concentration of TPrA, the more TPrA+• and TPrA• species can be produced, therefore 
the stronger the ECL (Scheme 3.3). As for the working electrode, Pt is clearly the most 
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favorable electrode for the DPAS/DBAE and SRUB/DBAE systems (Figures 3.11A and 
C), whereas mixed results are found when TPrA is used (Figures 3.11B and D). The 
combination of electrochemical oxidations of both ECL emitter and coreactant at a given 
electrode has probably played certain roles in determining the effect of the electrode 
material on ECL production. 
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Figure 3.11 Effect of coreactant concentration and electrode material on ECL intensity. 
Note: ECL measurements were conducted in 0.10 M PBS (pH 7.5) containing 7.5 µM ECL emitter of (A) and (B) DPAS, or (C) and 
(D) SRUB using coreactant of (A) and (C) DBAE, or (C) and (D) TPrA with a scan rate of 100 mV/s. Each point in the figure was an 
average result of three replicated tests.   
3.4.4 ECL enhancement with nitrate ions 
The ECL signals generated from the water soluble DPAS/DBAE and 
SRUB/DBAE systems were relatively weak. Inspired by the study published previously 
from this research group,281 where ECL determination of hexamethylene triperoxide 
diamine explosives was enhanced by silver nitrate in MeCN, we tested the effect of 
nitrate ions on the ECL production of the DPAS/DBAE and SRUB/DBAE systems. As 
shown in Figures 3.12, after addition of 10.0 mM NaNO3 to the above two systems, the 
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ECL peak intensity is increased by a factor of 13 (Figure 3.12A) and 11 (Figure 3.12B), 
respectively. CV responses indicate that much higher oxidation currents on the forward 
scan are seen for the DPA/DBAE-NaNO3 system as compared with the DPA/DBAE 
system alone (Figure 3.12A). On the other hand, however, only moderate increase in the 
forward oxidation currents is observed for the SRUB/DBAE-NaNO3 system (Figure 
3.12B). Moreover, CV responses are clearly shown to be affected by the ECL emitter 
present in the solution. This could be contributed partially to the electrocatalytic 
processes shown in Equations 3.8-3.9, where DPAS•+ produced electrochemically at the 
electrode oxidizes DBAE chemically in the solution, resulting in regeneration of DPAS. 
DPAS – e → DPAS•+ (heterogeneous electrochemical oxidation)  (3.8) 
DPAS•+ + DBAE →DPAS + DBAE•+ (homogeneous chemical reaction) (3.9) 
The above explanation is consistent with the oxidation peak potential of ~1.17 V 
for DPAS (Figure 3.6A) and ~0.9 V vs Ag/AgCl for DBAE, as well as with the small 
oxidation wave appeared at around 1.28 V vs Ag/AgCl on the forward scan of the CV in 
Figure 3.12A. Otherwise, the electrochemical oxidation of 7.5 M DPAS would not be 
seen in the presence of 25.0 mM DBAE. In the case of SRUB, the oxidation potential of 
~0.86 V vs Ag/AgCl (Figure 3.7A) for SRUB•+ is not sufficiently positive enough to 
oxidize DBAE. The presence of SRUB seems also to inhibitate the electro-oxidation of 
DBAE and nitrate ions, as in these cases, delayed and ill-defined oxidation processes are 
evident (Figure 3.12B) as compared with CVs in Figure 3.12A. Physical adsorption of 
SRUB on Pt could be responsible for this behavior.    
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Figure 3.12 Effect of nitrate ions on ECL from (A) DPAS/DBAE, and (B) SRUB/DBAE. 
Note: CV-ECL experiments were conducted in 0.10 M PBS (pH 7.5) containing (A) 7.5 µM SRUB-25.0 mM DBAE and (B) 7.5 µM 
DPAS-25.0 mM DBAE in the absence and presence of 10.0 mM NaNO3. A 2-mm diameter Pt and a scan rate of 100 mV/s were used.  
Close inspection of Figure 3.13 reveals that the enhanced ECL responses by 
nitrate ion have a less positive onset potential than that from a redox media without added 
NaNO3. Besides, the enhancement starts at ~0.80 V vs Ag/AgCl for the DPAS/DBAE-
NaNO3 system and ~1.00 V vs Ag/AgCl for the SRUB/DBAE-NaNO3 system. These two 
potential values are even less positive than the onset oxidation potential of NaNO3, i.e., 
~1.05 V vs Ag/AgCl (Figure 3.13a). As a result, the pre-enhancement of ECL is probably 
ascribed to the pre-oxidation of the ECL emitter and coreactant, which is facilitated by 
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the added NaNO3. Previous studies using FTIR spectroscopy
282 and indirect radiotracer 
method283 have confirmed the adsorption of NO3
- ions on Pt and other metal surfaces. 
During anodic potential scanning, such adsorption could prevent the formation of 
platinum oxides (e.g., PtO and PtO2),
284 therefore promoting the oxidation of 
electroactive species. As shown in Figure 3.13b, the onset oxidation potential of DBAE is 
shifted from 1.10 V to 0.75 V vs Ag/AgCl after the addition of NaNO3.  
2.0 1.5 1.0 0.5 0.0
E (V vs. Ag/AgCl)
 (c) DBAE
 (b) DBAE + NaNO
3
 (a) NaNO
3
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0.75 V
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Figure 3.13 CVs of (a) NaNO3, (b) DBAE-NaNO3, and (c) DBAE. 
Note: (a) CV measurements were conducted in 0.10 M PBS (pH 7.5) containing (a) 10 mM NaNO3, (b) 25.0 mM DBAE and 10.0 mM 
NaNO3, and (c) 25.0 mM DBAE at a 2-mm diameter Pt electrode with a scan rate of 100 mV/s. 
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The electrochemical oxidation of NaNO3 starts at ~1.05 V with an anodic peak 
potential of ~1.65 V vs Ag/AgCl (Figure 3.13c), which matches the ECL generation 
window of the DPAS/DBAE as well as SRUB/DBAE system. As will be discussed in 
detail later, the ECL enhancement originates from the electrochemical oxidation of nitrate 
ions.  
Figure 3.14 illustrates the effect of [NaNO3] on the ECL enhancement. With the 
increase of [NaNO3] from 0 to 8.0 mM, the ECL intensity for the DPAS/DBAE as well as 
the SRUB/DBAE system increases gradually. After [NaNO3] reaches 9.0 mM, the 
enhancement levels off. Notice also that the effect of ECL enhancement by NaNO3 is 
more significant towards the SRUB/DBAE system than the DPAS/DBAE system. 
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Figure 3.14 Effect of [NaNO3] on the ECL enhancement of (a) SRUB/DBAE and (b) 
DPAS/DBAE system. 
Note: ECL intensity at peak was used and other experimental conditions were the same as listed in Figure 3.9.    
The above remarkable ECL enhancement by NaNO3 is further testified by the 
data shown in Figure 3.15, where ECL signals are acquired with the spectral ECL 
instrument reposted in Chapter II rather than a highly sensitive photodetector 
photomultiplier tube (PMT). With the addition of NaNO3 into the mixed (DPAS-
Ru(bpy)3
2+)/DBAE system, quantification of originally undetectable ECL signals is 
realized.  
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Figure 3.15 Demonstration of ECL enhancement by NaNO3 using the mixed (DPAS-
Ru(bpy)3
2+)/DBAE system. 
Note: (a) ECL spectra of [DPAS] from 2.5 to 7.5 µM, mixed with a constant [Ru(bpy)3
2+] of 1.0 µM, and (b) ECL spectra obtained 
after addition of 10.0 mM NaNO3 to solutions described in (a). All data were collected from the homemade spectral ECL instrument 
with a linear sweep voltammetry from 0 to 2.0 V vs Ag/AgCl at 100 mV/s. 
Previously,281 AgNO3 was used as an ECL enhancing agent in MeCN, and both 
Ag+ and NO3
- ions were found to be responsible for ECL enhancement. In the present 
study, however, AgNO3 cannot be used because Ag
+ ion can react with phosphate buffer 
to form silver precipitates. To verify if the cations of nitrate salts would play any role 
during the process of ECL enhancement, nitrate salts with various cations M (M = Li+, 
Na+, K+, and NH4
+) were added to a well-understood Ru(bpy)3
2+/DBAE system. The 
resultant ECL profiles are shown in Figure 3.16, suggesting that nitrate ion is solely 
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responsible for the ECL enhancement. Compared with data shown in Figure 3.12, ECL 
profiles of the Ru(bpy)3
2+/DBAE-MNO3 system are extended to a much broad potential 
range with a clear pre-enhancement feature. This broadening effect is consistent with the 
electrochemical oxidation behavior of NaNO3 (Figure 3.13a), and is probably an 
indication of R•– stability in the solution (see Scheme 3.4 for details). In other words, the 
anion radicals of the three tested ECL emitters follow a stability order of Ru(bpy)3
 + > 
SRUB•– > DPAS•–. 
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Figure 3.16 Effect of different nitrate salts on the ECL enhancement of the 
Ru(bpy)3
2+/DBAE system. 
Note: ECL measurements were conducted in 0.10 M PBS buffer (pH 7.5) containing 7.5 μM Ru(bpy)3
2+ and 25.0 mM DBAE in in the 
absence and presence of 10.0 mM of LiNO3, KNO3, NH4NO3, and NaNO3 at a 2-mm diameter Pt electrode with a scan rate 100 mV/s. 
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On the basis of the data presented above and previous studies,281,285-287 it is 
believed that the significant ECL enhancement of the R/DBAE system with nitrate ions is 
associate with the chemical oxidation reactions of nitrate free radical (NO3
•) generated 
electrochemically (Equation 3.10) with the ECL emitter R (Equation 3.11), coreactant 
DBAE (Equation 3.12), and R•– (Equation 3.13), forming species that are crucial for ECL 
emissions. The NO3
•/NO3
- couple has an estimated standard redox potential of ~1.80 V vs 
Ag/AgCl,39 which is consistent with the oxidation peak potential of 1.65 V vs Ag/AgCl 
for NaNO3 in aqueous media (Figure 3.13a) and that of ~1.63-1.9 V vs Ag/AgCl for NO3
- 
in MeCN.285-287 Scheme 3.4 is the proposed ECL mechanism of the R/DBAE-NO3
- 
system using DBAE as an anodic ECL coreactant and NO3
- as an ECL enhancing agent, 
where Equations 3.10-3.13 are highlighted and contributed to the ECL enhancement. 
DBAE −  e →  DBAE•+  (electrochemical oxidation)   (3.1) 
R −  e →  R•+   (electrochemical oxidation)   (3.2) 
DBAE•+ − H+  →  DBAE•  (deprotonation)    (3.3) 
R•+  +  DBAE•  →  R∗  (chemical reduction)    (3.4) 
R +  DBAE•  →  R•−   (chemical reduction)    (3.5) 
NO3
−  −  e →  NO3
•    (electrochemical oxidation)   (3.10) 
R +  NO3
•   →  R •+  (chemical oxidation)    (3.11) 
NO3
•  +  DBAE →  DBAE•+ (chemical oxidation)    (3.12) 
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NO3
•  +  R•− →  R∗  (excited state formation)   (3.13) 
R•+  +  R•−  →  R∗  +  R   (excited state formation)   (3.6) 
R∗  →  R +  hv   (ECL generation)     (3.7)  
(R = DPAS, SRUB, or Ru(bpy)3
2+, DBAE = (CH3CH2CH2CH2)2NCH2CH2OH) 
Scheme 3.4 Proposed ECL mechanism of the R/DBAE-NO3- system using DBAE as an 
anodic ECL coreactant and NO3
- as an ECL enhancing agent. 
3.4.5 Direct EPR Evidence of Nitrate Free Radical (NO3•) 
To verify if nitrate free radical exists in the chemical environment similar to the 
ECL media, EPR spectroscopy of potassium nitrate was performed in an aqueous 
solution. The use of a regular quartz EPR tube is not appropriate because the heating of 
the aqueous solution by microwave resulting in the tuning of the EPR instrument to be 
difficult. Consequently, a small glass capillary tube was used to hold the test solution. 
Although photolysis of nitrate can involve a series of complicated reactions,288-290 both 
NO3
• and OH• free radicals are expected to form first before they are caught by spin 
trapping agent DMPO (Equations 3.14-18). The EPR signals are produced from the 
respective stable DMPO/radical adducts, whose chemical structures are shown in Scheme 
3.5.  
NO3
- + hv → (NO3-)*        (3.14) 
H2O + hv → (H2O)* → OH• + H•       (3.15) 
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(NO3
-)* + OH• → NO3• + OH-      (3.16) 
DMPO + OH• → DMPO/OH•       (3.17) 
DMPO + NO3
• → DMPO/NO3•       (3.18) 
 
Scheme 3.5 Formation of DMPO/NO3• and DMPO/OH• adducts. 
Figure 3.17 shows the experimental and simulated EPR spectra of aqueous KNO3 
mixed with DMPO under UV irradiation. The reason to choose KNO3 instead of NaNO3 
was because KNO3 had higher purity than NaNO3, thus potential impurity interfaces to 
EPR production were minimized. The experimentally obtained EPR spectra (Figure 
3.17a) consist of peaks from two types of DMPO/radical adducts, where peaks labelled 
with “*” are from DMPO/OH• radicals and ones with “&” labeling are from DMPO/NO3• 
radicals. These assignments are supported by EPR simulations presented in Figures 3.17c 
and d, respectively, using Winsim software. Although DMPO/OH• EPR spectra have 
been widely reported,288,291-296 no EPR spectra on DMPO/NO3
• radicals is found. For 
DMPO/OH• simulation, the hyperfine coupling of the unpaired electron with the N 
nucleus and H nucleus was considered. The same coupling constants (aN = 14.85 G 
and aH = 14.85 G) taken from a previously published paper of this research group on 
hydroxyl radical EPR were used.281 For DMPO/NO3
• simulation, in addition to the 
 108 
coupling between the unpaired electron and the N nucleus (aN = 14.85 G), 
contributions from the -H with two possible conformation sites are included.293. These 
two sites in chemical exchange should have close hyperfine coupling constants as found 
out during the optimization of simulation (aH1 = 13.85 G and aH2 = 13.70 G). The 
combination of the above two simulated EPR spectra is illustrated in Figure 3.17b, which 
matches well with the experimentally obtained one (Figure 3.17a).  
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Figure 3.17 Experimental and simulated EPR spectra for nitrate mixed with DMPO in 
water under UV irradiation.  
Note: EPR spectra were obtained from UV irradiation of 0.10 M KNO3 with 200 mM 5,5′-dimethyl pyrroline-N-oxide (DMPO as spin 
trap) in aqueous media, using a resonant frequency of 9.86 GHz, a modulation frequency of 100 kHz, a microwave power of 2.697 
mW, and a time constant of 32 ms. The EPR spectra were the collection of 4 consecutive scans. (a) Experimental, (b) overall 
simulation, (c) simulation of DMPO/OH•, and (d) simulation of DMPO/NO3•. The following hyperfine coupling constants were used: 
for (c) aN = 14.85 G and a
H = 14.85 G, and for (c) a = 14.85 G, a
H1 = 13.85 G, and a
H2 = 13.70 G. 
EPR spectra from solid sodium nitrate irradiated with X or  rays have been 
previously reported.297 
 110 
3.4.6 ECL Studies of Mixed Systems of DPAS, SRUB, and Ru(bpy)32+ 
ECL titration study was first undertaken to examine possible interactions between 
DPAS and SRUB, whose ECL emissions are at ~ 420 nm and ~ 550 nm, respectively. 
Attempts to collect ECL spectra from the binary mixed system of DPAS-SRUB, where 
the concentration of SRUB was increased while keeping the concentration of DPAS 
constant, were unsuccessful, because concentrations of DPAS and SRUB larger cannot 
be larger than 10 μM in sodium phosphate buffer as mentioned in Chapter II. At such low 
concentrations, ECL spectra were too weak to be recorded. Upon addition of nitrate (10 
mM optimal concentration) to the system, ECL spectra immediately became detectable. 
Figure 3.18A shows the ECL spectra of the (DPAS-SRUB)/DBAE-NO3
- system with a 
constant concentration of DPAS at 2.50 μM mixed with different concentrations of 
SRUB. With the increase of SRUB concentration, ECL intensity at ~550 nm for SRUB 
emissions increases as expected. Meanwhile, the ECL intensity at ~420 nm for DPAS 
remains essentially unchanged. The inset in Figure 3.18A displays the linear responses of 
ECL intensities with the increase in the concentration of SRUB. This finding suggests 
that the energy transfer interactions between the two emitters are insignificant at low 
concentrations, which is different from the cases in Chapter II when higher 
concentrations of emitters were used. 
Figure 3.18B shows the ECL spectral data for the mixed (DPAS-
Ru(bpy)3
2+)/DBAE-NaNO3 system, where ECL emissions from DPAS and Ru(bpy)3
2+ 
increase with the increase of Ru(bpy)3
2+ concentration due to the energy transfer 
interactions as described in Chapter II.  
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Figure 3.18 ECL spectra of (A) (DPAS-SRUB) /DBAE-NaNO3 and (B) (DPAS-
Ru(bpy)3
2+)/DBAE-NaNO3. 
Note: 25.0 mM DBAE as ECL coreactant and 10.0 mM NaNO3 as ECL enhancing agent were used. All ECL-intensity measurements 
were carried out in 0.10 M sodium phosphate buffer (pH 7.5). A 2-mm diameter Pt electrode and a scan rate of 100 mV/s were 
applied. LN CCD camera was used as detector. 
Figure 3.19A shows the ECL spectra of mixed DPAS-SRUB-Ru(bpy)3
2+ system 
in the presence of 25.0 mM DBAE and 10.0 mM NaNO3. With the increase of Ru(bpy)3
2+ 
concentration, ECL intensity of DPAS increases slightly, and the ECL for SRUB remains 
unchanged as displayed in the inset after spectral deconvolution (see Sections 2.3.5 and 
2.3.6 of Chapter II for detail). Figure 3.19B shows the effect of SRUB concentration 
changes on ECL signal changes of DPAS and Ru(bpy)3
2+. In this case, with the increase 
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of SRUB concentration, ECL signal changes for both DPAS and Ru(bpy)3
2+ increase due 
to energy transfer interactions.   
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Figure 3.19 ECL spectra (DPAS-SRUB-Ru(bpy)32+)-NaNO3/DBAE with the 
concentration change of (A) Ru(bpy)3
2+) and (B) SRUB. 
Note: Experiments were carried out with 10.0 mM NaNO3 as ECL enhancing agent.in 0.10 M sodium phosphate buffer, pH 7.5. A 2-
mm diameter Pt electrode and a scan rate of 100 mV/s were applied. LN CCD camera was used as detector. 
3.5 Conclusion 
Water soluble analogues of DPA and RUB, i.e., DPAS and SRUB, were 
synthesized and characterized by electrochemical and ECL studies. The CV and ECL 
behavior of both DPAS and SRUB was very similar (in terms of redox potential, ECL 
emission wavelength, ECL generation potential window, etc.) to that of their precursors 
DPA and RUB. The weak ECL emissions of both DPAS and SRUB with DBAE as 
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anodic ECL coreactant were enhanced with nitrate salt. More than 10 times enhancement 
in ECL intensity was found for all three ECL emitters when 10.0 mM NaNO3 was used. 
This effect was believed to be ascribed to the formation of NO3
• free radical, which was 
confirmed by EPR spectra obtained from solution phase KNO3 under UV irradiation in 
the presence of DMPO as spin trapping agent. Finally, ECL responses from mixed ECL 
emitter systems were studied, where energy transfer interactions occurred, although such 
effects may be insignificant at a much lower concentration range.  
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CHAPTER IV – DIRECT ELECTRON PARAMAGNETIC RESONANCE EVIDENCE 
OF CATHODIC ECL COREACTANT INTERMEDIATES OF BENZOYL PEROXIDE 
AND AMMONIUM PERSULFATE  
4.1 Introduction 
Coreactant electrogenerated chemiluminescence (ECL) is a type of ECL that is 
generated from an ECL emitter (R) mixed with a deliberately added chemical termed 
“coreactant” (C) upon anodic or cathodic potential scanning.72,81 For anodic coreactant 
ECL (Scheme 4.1), C along with R is first electrochemically oxidized to form C•+ and 
R•+, which is immediately followed by a homogeneous chemical dissociation that 
converts C•+ to a strongly reducing agent C• free radical. C• then chemically reduces R to 
R•–. Finally, R•+ annihilates with R•– to produce the excited state R* that emits light.  
C – e → C•+  (electrochemical oxidation)    (4.1) 
R – e → R•+  (electrochemical oxidation)    (4.2) 
C•+ → C•  (chemical decomposition)    (4.3) 
C• + R → R•–   (chemical reduction of R)    (4.4) 
R•+ + R•– → R* (ion annihilation)     (4.5) 
R* → R + hv  (ECL emission)     (4.6) 
Scheme 4.1 A general ECL mechanism of an anodic ECL system with R served as an 
ECL emitter and C as a coreactant. 
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On the other hand, for cathodic coreactant ECL (Scheme 4.2), C along with R is 
first electrochemically reduced to form C•– and R•–, which is immediately followed by a 
homogeneous chemical decomposition reaction that converts C•– to a strongly oxidizing 
agent C• free radical. C• then chemically oxidizes R to R•+. Finally, R•+ annihilates with 
R•– to produce the excited state R* that emits light.  
C + e → C•–  (electrochemical reduction)    (4.7) 
R + e → R•–  (electrochemical reduction)    (4.8) 
C•+ → C•  (chemical decomposition)    (4.9) 
C• + R → R•+   (chemical oxidation of R)    (4.10) 
R•+ + R•– → R* (ion annihilation)     (4.5) 
R* → R + hv  (ECL emission)     (4.6) 
Scheme 4.2 A general ECL mechanism of a cathodic ECL system with R served as an 
ECL emitter and C as a coreactant. 
Examples of commonly used R include 9,10-diphenylanthracene (DPA), rubrene 
(RUB), Ru(bpy)3
2+, and their derivatives. Two commonly used anodic coreactants C are 
tri-n-propylamine (TPrA) and 2-(dibutylamino)ethanol (DBAE), and benzoyl peroxide 
(C6H5COOOCC6H5 or BPO) and persulfate (S2O8
2-) are examples of two cathodic ECL 
coreactants. Coreactant ECL has been well studied and widely used in chemical and 
biochemical analysis. The proposed ECL mechanism is also broadly accepted; however, 
very limited experimental evidence in the literature that directly show the presence of 
 118 
coreactant intermediates (i.e., C•+, C•–, or C•). This is probably because these cation, 
anion, or neutral free radicals are short-lived, unstable, and very reactive, which is 
supported by the fact that cyclic voltammetric responses of these coreactants only show 
irreversible behavior, even at a very fast scan rate (ν = 5000 mV/s). 
Given the fact that all aforementioned coreactant intermediates have unpaired 
electrons, electron paramagnetic resonance (EPR) spectroscopy or electron spin 
resonance (ESR) spectroscopy could be a powerful technique to probe these species. EPR 
measures the absorption of electromagnetic radiation with a wavelength in microwave 
region (in the order of a few cm) by a sample with unpaired electron under an external 
magnetic field. Unlike NMR, where nuclear spins are excited, in EPR the electron spins 
are excited. EPR spectra is a display of the first order differentiation or derivative of 
absorbance. Experimentally, EPR spectrum is often measured by holding microwave 
frequency constant while sweeping the magnetic field, and the power absorbed is 
acquired as a function of the applied magnetic field. 
EPR has been used to study a variety of reactive oxygen species (ROS) including 
peroxides, superoxide, hydroxyl radical, and singlet oxygen as well as reactive nitrogen 
species (RNS)298-300. EPR spectroscopy has been applied for online monitoring of species 
of environmental concerns,301-305 thermally generated radicals,306 polymers,307 proteomics 
and genome-wise expression studies,308 transition-metal proteins (metalloproteins),309-314 
bio-medical, clinical and pharmaceutical applications,315-318 DNA-metal complex 
interactions, biologically relevant free radicals in cellular, ex vivo, and in vivo 
systems.319-322 
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Previously, EPR evidence of TPrA•+, the radical cation intermediate formed after 
TPrA oxidation, was reported.216 Reports323,324 on BPO generating BPO• (i.e., 
benzoyloxyl radical C6H5COO
•) in solid state are also available. In this chapter, EPR data 
of cathodic coreactant intermediates BPO• radical generated from BPO and SO4
•– anion 
radical generated from persulfate (S2O8
2-) are presented. The electrochemical and 
chemical reaction pathways of generating BPO• from BPO at electrode surface have been 
described in Scheme 2.1 in Chapter II. Moreover, BPO yielded the strongest ECL 
emission in comparison to TPrA and DBAE when mixed with ECL emitter DPA, RUB, 
or Ru(bpy)3
2+ (Chapter II). BPO and persulfate have similar ECL mechanisms and both 
contain common ECL peroxide linkage moiety (-O-O-), allowing one to generate their 
intermediates using similar strategy. 
4.2 Experimental Section 
4.2.1 Chemicals and materials 
Benzoyl peroxide (BPO, C14H10O4, 97%) was purchased from Aldrich. 
Ammonium persulfate or ammonium peroxydisulfate ((NH4)2S2O8, 98%) was obtained 
from Fluka. Hydrazine hydrate (N2H4), acetonitrile (HPLC grade), 5,5-dimethyl-1-
pyrroline-N-oxide (DMPO, ≥98%) were obtained from Cayman Chemical (Ann arbor, 
MI). For measuring organic samples, a thin quartz EPR tube with outer diameter (OD) 
4.0 mm, inner diameter (ID) 3.0 mm, wall thickness 0.5 mm, and 250 mm long from 
Wilmad Lab Glass (PA) was used. For measuring EPR spectra in water, a standard glass 
capillary (100 mm long, 2/0.5, OD/ID (mm), World Precision Instruments, Inc., Sarasota, 
FL) was utilized. 
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Figure 4.1 Block diagram of EPR instrumentation. 
Note: (a) Microwave radiation source (klystrons or gun oscillator), (b) sample cell, (c) d.c. magnetic field and a sweeping circuit for 
changing the magnetic field, (d) detection system, and (e) data acquisition.  
The block diagram of EPR instrumentation is shown in Figure 4.1.The 
experimental setup consists of (a) microwave radiation source (klystrons or gun 
oscillator) that provides a power output of about 300 mW holding the frequency constant, 
(b) a sample cell placed in the cavity where the microwave is transmitted through 
waveguide to convey the wave radiation to the sample, (c) a d.c. magnetic field and a 
sweeping circuit for changing the magnetic field., (d) a detection system (basically a 
rectifier crystal) for measuring the absorption, and (e) a data acquisition and a phase 
sensitive signal processing unit. 
4.2.2 EPR parameters and acquisition 
EPR spectroscopy was performed with a Bruker EMX microX EPR spectrometer 
equipped with an ER 4119HS standard cylindrical resonator (Bruker BioSpin Corp.). Pre-
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calibration was done using the manufacturer’s 2,2-diphenyl-1-picrylhydrazyl (DPPH), 
1,3-bisdiphenylene-2-phenylallyl (BDPA), and weak pitch standard calibration samples. 
Unless otherwise stated, all the EPR measurements were conducted at room temperature 
20 ± 2 °C. 
4.2.3 Spin labels (traps) 
When the free radical or the molecule with unpaired electron is very unstable or 
has a very short life (order of nano to pico second), then a spin trap (label) is used. Spin 
traps are organic molecules having unpaired electrons. Most common spin traps are the 
class of nitrones (Figure 4.2) and have the ability to bind to the molecule (EPR inactive) 
and convert them to EPR active forming spin trap/ molecule adduct.  
 
Figure 4.2 Chemical structures of common nitroxide spin labels (traps). 
Note: TMPO = (3,3,5,5-tetramethyl-1-pyrroline-1-oxide), DMPO = (5,5-dimethyl-1-pyrroline N-oxide), and PBN = alpha-phenyl N-
tertiary-butyl nitrone. 
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4.3 Results and Disussion 
4.3.1 Measurement of EPR spectra of benzoyloxy free radical (BPO• or PhCO2•) 
 
Scheme 4.3 Formation of benzoyloxy radical (BPO•) by chemically reducing BPO with 
hydrazine, followed by spin trapping with DMPO. 
As shown in Scheme 4.3, BPO is reduced by hydrazine to (PhC(O)O)2
- that 
further decomposes to benzoyloxy radical (BPO•) and PhC(O)O-. Finally, BPO• reacts 
with the spin trapping agent DMPO to form EPR active DMPO/BPO• adduct. The EPR 
spectra of such a system is shown in Figure 4.3, where (a) is the experimentally obtained 
spectra, and (b) is the simulation of (a). Considering the adduct structure (Scheme 4.3), 
the unpaired electrode could couple with -N, -H (two possible conformation sites),293 
and 2 -H.292  The simulated EPR spectra (Figure 4.3b) essentially matches the 
experimental one. The simulated EPR spectra of hydroxyl radical (Figure 4.3c) does not 
match the experimental one, especially the first peak at ~3485 G, suggesting that no 
significant hydroxyl radical is formed under current experimental conditions. This is 
easily understood, because in the reaction media, the initial concentration ratio of 
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DMPO/BPO was 20, and newly produced BPO• free radicals were immediately caught by 
DMPO, so that no free BPO• was left for water oxidation and OH• free radical 
production. 
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Figure 4.3 EPR spectra of DMPO/•OOC6H5 adduct. 
Note: 10.0 mM BPO was chemically reduced by 75.0 μM hydrazine and 200.0 mM DMPO was used as the spin trapping agent in 
MeCN-H2O mixture media. The experimental parameters were: microwave power = 2.69 mW, resonant frequency = 19 GHz, Q value 
= 8900, time constant = 20.48 ms, Modulation amplitude = 4 G. The EPR spectra was the average of 4 consecutive scans. For 
simulation of spectra (b), a = 14.85 G, a
 = 10.00 G, a
H’ = 8.80 G, a
H1 = 2.15 G, and a
H2 = 1.00 G were used. For simulation of 
DMPO/OH• spectra shown in (c). aN = a
H = 14.85 G were used. 
Under UV irradiation, solid and solution phase benzoyloxy peroxide radicals are 
produced as indicated in Equation 4.11.  
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(PhC(O)O)2 + hv → (PhC(O)O)2* → 2(PhC(O)O•)    (4.11) 
Figure 4.4A shows the EPR spectra from solid BPO without DMPO using UV 
irradiation. Simulations of these spectra were found to be challenging and further 
investigations are needed.   
When solid BPO was mixed with a drop of 200 mM DMPO, and undertaken 
irradiation of UV, the obtained EPR spectra (Figure 4.4B) were found to be very similar 
to those resulted from the chemical reactions of BPO and hydrazine (Figure 4.3a), 
confirming that the same radical (i.e., BPO•) was produced from the two-different means. 
Again, in Figure 4.4B, DMPO/OH• adduct seems to be not present. 
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Figure 4.4 EPR spectra obtained from (A) solid BPO without DMPO under UV 
irradiation, and (B) solid BPO mixed with a drop of 200 mM DMPO solution under UV 
irradiation. 
Note: EPR experimental parameters were the same as in Figure 4.4. 
4.3.2 Measurement of EPR spectra of sulfate anion radical (SO4•-) 
Under UV irradiation, solid or solution phase persulfate forms sulfate anion 
radical (SO4
•-), which further reacts with the added DMPO to produce EPR active adduct 
(Equations 4.12-13).  
S2O8
2- + hv → (S2O82-) * → 2(SO4•-)      (4.12) 
SO4
•- + DMPO → DMPO/SO4•-      (4.13) 
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Persulfate anion radical can also be produced through chemical reactions between 
persulfate and hydrazine (Equation 4.14).   
S2O8
2- + N2H4 → S2O83- → SO42- + SO4•-     (4.14) 
Figure 4.5A shows the EPR spectra of solid persulfate with DMPO under UV 
irradiation and Figure 4.5B shows solution phase EPR spectra of persulfate in water with 
hydrazine and DMPO in the absence of UV irradiation. Clearly, many more EPR signals 
are present in the second case, which probably due to the existence of DMPO/OH• adduct 
formed from the following reaction (Equation 4.15).325 
 SO4
•- + OH- → SO42- + OH•       (4.15) 
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Figure 4.5 EPR spectra of (A) solid persulfate with DMPO under UV irradiation, and (B) 
persulfate in water with hydrazine and DMPO without UV irradiation. 
Note: (A) EPR spectra were obtained with a resonant frequency of 9.87 GHz, a modulation frequency of 100 kHz, microwave power 
of 9.93 mW. and time constant of 327.68 ms. The concentrations of ammonium persulfate and DMPO were 10 mM and 200 mM, 
respectively. (B) EPR spectra were obtained with a resonant frequency of 9.87 GHz, attenuation 10 dB, a modulation frequency of 
100 kHz, microwave power of 18.97 mW. and time constant of 20.48 ms.  The concentrations of ammonium persulfate, hydrazine, 
and DMPO were 10 mM, 75 µM, and 200 mM, respectively. The EPR spectra is the collection of 4 consecutive scans.  The EPR 
spectra is the collection of 4 consecutive scans. 
4.4 Conclusion 
The free radical intermediates of cathodic coreactants such as ammonium 
persulfate and BPO generates sulfate anion radical (SO4
•-) and benzoyloxy free radicals 
(C6H5CO2
• or BPO•) after electrochemical reduction of the coreactants in aqueous and 
acetonitrile respectively. The direct EPR evidence of such free radical intermediates 
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generated was mimicked by reducing these ECL coreactants chemically by hydrazine as 
the reducing agent and DMPO as the spin trapping agent. Both DMPO (as spin trap) and 
hydrazine (as reducing agent) respectively are needed to obtain the EPR spectrum 
C6H5CO2
• or BPO• in solution phase in MeCN solvent. Whereas neither the spin trap nor 
the reducing agent are needed to obtain EPR spectrum of solid BPO which just needed 
UV irradiation. The EPR spectra obtained from solid phase (with and without UV 
irradiation) are very similar. For solution phase BPO in MeCN-H2O mixed solvent, it is 
easy to tune the system in capillary tube rather than using the regular quartz EPR tube. 
The EPR spectra of persulfate radical anion in aqueous medium using hydrazine as the 
reducing agent and DMPO as the spin trapping agent as well as solid phase with UV 
irradiation with DMPO spin trapping were collected and interpreted. For solution phase 
persulfate in aqueous medium, it was easy to tune the system in capillary tube and could 
not be tuned with a regular quartz EPR tube because aqueous solution can be heated by 
the microwave resulting drift of the signals.  
Some EPR spectra presented in this chapter need to be simulated so that identity 
of the radicals can be confirmed.  
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CHAPTER V – ULTRASENSITIVE ELECTROGENERATED 
CHEMILUMINESCENCE BASED IMMUNOASSAYS FOR THE DETECTION OF 
ZIKA AND DENGUE VIRUSES1  
5.1 Introduction 
Zika virus (ZIKV) is a member of the Flavivirus genus of the Flaviviridae family, 
which includes other globally important pathogens, such as West Nile (WNV), dengue 
(DENV), and yellow fever viruses.326,327 Recent outbreaks of ZIKV have linked this 
previously neglected virus to the development of severe fetal abnormalities including 
spontaneous abortion, stillbirth, microcephaly, and Guillain-Barré syndrome (GBS), a 
neurological disorder.328 Autochthonous transmission of ZIKV infection has been 
reported in Asia, Africa, Micronesia, and Latin America with increasing descriptions of 
travel related cases worldwide.329-333 Since the Aedes species of mosquitoes that transmit 
ZIKV circulate globally, there is a significant risk of ZIKV spread worldwide.334,335 Thus, 
ZIKV is Organization estimated that as many as four million people could have be 
infected in American countries in 2016.336 Currently, there is no approved therapy or 
vaccine against ZIKV. 
Dengue virus (DENV), on the other hand, is believed to be a leading cause of 
illness and death in the tropics and subtropics, where about one-third of the world’s 
population could be at risk for infection, as reported by the Centers for Disease Control 
and Prevention. There are four serotypes of DENV (i.e., DENV1, DENV2, DENV3, and 
                                                 
1Part of this work has been published: Acharya, D.; Bastola, P.; Le, L.; Paul, A. M.; Fernandez, E.; 
Diamond, M. S.; Miao, W.; Bai, F., An ultrasensitive electrogenerated chemiluminescence-based 
immunoassay for specific detection of Zika virus. Sci. Rep. 2016, 6, 32227. 
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DENV4), all of which are transmitted by mosquitoes and could cause up to 400 million 
people infected each year. Unfortunately, no any vaccines to prevent infection with 
DENV is currently available.  
Similar to DENV, WNV and chikungunya virus (CHIKV), ZIKV infection in 
humans can result in a range of clinical signs and symptoms including fever, rash, joint 
pain, and conjunctivitis, which poses a challenge for differential diagnosis of these viral 
infections as they often are co-transmitted in the same areas.337,338  
In addition, ZIKV has been detected in semen, urine, and saliva,339-341 suggesting 
a potential for transmission through routes other than mosquito bite, such as sexual 
contact.342-344 Therefore, a highly sensitive and specific method for detection of ZIKV is 
urgently needed to facilitate efficient case management, surveillance, and implementation 
of control programs. Current methods for detection and diagnosis of ZIKV DENV 
infections include nuclear acid-based assays, such as quantitative polymerase chain 
reaction (qPCR), and antibody-based assays, such as enzyme-linked immunosorbent 
assay (ELISA) or neutralization tests.345-347 Since the conventional nuclear acid-based 
assays require expensive reagents and instruments, and ELISAs are time consuming and 
have specificity concerns,348,349 a rapid and simple-to-use methodology with high 
sensitivity, reliability, and cost effectiveness is needed.350,351  
Electrogenerated chemiluminescence (ECL) is a phenomenon of light emission by 
an excited state of species generated at electrodes that undergoes high-energetic electron-
transfer reactions.113 The emitted light can be measured easily by simple 
instrumentation,113,155 thus providing an efficient sensor for rapid and simple-to-use 
 131 
devices for separation, detection, and quantification of a diverse range of analytes in a 
small quantity (up to femtomolar scale) of starting sample. Applications of ECL-based 
detection have been demonstrated successfully in a wide range of immunological and 
molecular assay systems including clinical diagnosis,155,163,352 biosensing,353-355 drug 
assays,356 food quality analysis,357,358 environmental monitoring,161,359 and forensic 
chemistry.360-362 Several strategies have been developed to optimize and amplify ECL 
detection signals. For example, it has been previously reported that the polystyrene beads 
(PSBs) could be loaded with several billions of water-insoluble homemade 
Ru(bpy)3[B(C6F5)4]2 (bpy = 2,2'-bipyridine) ECL labels. This step increased the ratio of 
ECL label to bioanalyte and amplified ECL signals by several order of magnitudes.155,156 
By conjugating ECL label-loaded PSBs with specific antibody or antigen, a highly 
sensitive detection platform of diverse repertoire of analytes can be achieved. 
In this chapter, highly sensitive and specific ECL-based immunoassays for 
detection and quantification of ZIKV and DENV4 in biological fluids with a limit of 
detection of 1 plaque-forming unit (PFU) in 100 μL of samples are reported. The rubrene 
(RUB)/benzoyl peroxide (BPO) system will be our choice of sensing, because it showed 
the most efficient ECL emissions in MeCN as described in Chapter II. This study 
provides an essential proof-of-concept that ECL-based immunoassays can be developed 
for the detection and quantification of viruses. 
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5.2 Experimental 
5.2.1 Chemicals and reagents 
Monoclonal antibody (mAb) against ZIKV (ZV2, IgG2c) specifically recognizes 
the E protein on ZIKV and was generated after immunization of mice with infectious 
ZIKV.363 Mouse mAb specific to flaviviruses (4G2) was produced and purified by 
culturing hybridoma (HB-112, ATCC) as previously described.364 Carboxylate 
polystyrene beads (referred as PSB, 10 μm diameter, 2.6% (w/w) aqueous suspension 
with approximately 6.5 × 104 beads μL-1) and streptavidin-coated super-paramagnetic 
polystyrene beads (referred as MB, 1.0 μm diameter, 10 mg mL-1 aqueous suspension 
with approximately 9.5 × 106 beads μL-1) were purchased from PolySciences Inc. and 
Dynal Biotech Inc., respectively. Other reagents were purchased from either Sigma or 
other commercial vendors. 
5.2.2 Preparation and titration of virus stocks 
A recent strain of ZIKV (PRVABC59) was obtained from B. Johnson (CDC 
Arbovirus Branch, Fort Collins CO). CHIKV (LR-OPY1-2006 strain) was provided by R. 
Tesh (University of Texas Medical Branch). WNV isolate (CT2741) and the four 
serotypes of dengue viruses (DENV1, DENV2, DENV3, and DENV4) were provided by 
J. Anderson (Connecticut Agricultural Experiment Station). WNV, ZIKV, and CHIKV 
were propagated in African green monkey kidney cells (Vero cells, ATCC CCL-81) and 
DENV (DENV1, DENV2, DENV3 and DENV4) were propagated in C6/36 Aedes 
albopictus cells. All virus stocks were titered in Vero cells (ATCC CCL-81) by plaque 
assay as previously described.365 
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5.2.3 ECL label loading and avidin conjugation of PSBs. 
Loading of ECL-labels to PSBs was performed as previously described 113,156 with 
some modifications. Briefly, carboxylated PSBs were loaded with RUB by immersing the 
beads into a saturated solution of RUB (∼0.7 mM) in 5% benzene–95% MeOH (v/v) for 
2 h, followed by a series of centrifugation, washing, and drying. Prepared PSBs were 
designated as PSB(RUB). For avidin conjugation, the PSB(RUB) beads were reacted 
with a freshly prepared avidin solution (25 μM), activated in a 1-methylimidazole-HCl 
buffer (0.10 M, pH 7.2) containing 0.10 M EDAC and 0.10 M NHS for 1h, followed by 
centrifugation, washing and re-suspension in PBS buffer (pH 7.2). The final solution 
containing approximately 6.5 × 104 μL-1 of avidin conjugated PSB(RUB) beads was 
stored at 4 °C until use. 
5.2.4 Attachment of biotinylated antibodies to the surface of ECL-label loaded PSBs 
and MBs. 
Biotinylation of antibody was performed as described.155 Biotinylated antibody 
was immobilized on the surface of ECL-label loaded PSBs by mixing 400 μL of avidin-
coated beads with 1.5 mL of biotinylated antibody (0.05 mg/ml) and rotating the mixture 
in a Dynal sample mixer at 20 rpm for 1 h. Free antibodies then were removed from the 
newly formed mAb-PSB(RUB) conjugates by washing four times with PBS and 
conjugates were re-suspended in 400 μL of PBS (pH 7.2). Likewise, freshly washed MBs 
corresponding to 100 μL of the original MBs suspension was immersed in 1.5 mL of 
0.05 mg/mL of biotinylated antibody, and the mixture was then rotated with a Dynal 
sample mixer at 20 rpm for 1 h. Newly formed mAb-MB conjugates were separated from 
the solution mixture with a magnet (Dynal MPC-S), followed by washing and re-
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suspension in 100 μL of PBS buffer (pH 7.2). The resulting mAb-MB and mAb-
PSB(RUB) conjugates were stored at 4°C until use. 
5.2.5 ECL and electrochemical measurements 
To measure ECL-intensity, aggregates were dissolved in a 2.0 mL solution of 
10.0 mM BPO-0.10 M TBAP in MeCN for optimized ECL measurements (see results for 
details). A three-electrode system with a 2.0-mm diameter Pt disk as the working 
electrode, a Pt wire as the counter electrode, and a Ag/Ag+ (10 mM AgNO3 and 0.10 M 
TBAP in MeCN) as the reference electrode were used. All three electrodes were 
incorporated in a 5-mL disposable glass vial cell containing assay samples. Before each 
measurement, the Pt electrode was polished with a 0.3 μm alumina slurry, and all 
electrodes were cleaned carefully by washing with excess water followed by rinsing with 
MeCN. The ECL intensities along with the cyclic voltammetry signals (CV) were 
recorded simultaneously in a home-built ECL instrument as described previously.161 This 
instrument consists of a 660A electrochemical workstation (CH Instruments, Austin, TX, 
USA) combined with a photomultiplier tube (PMT, Hamamatsu R928, Japan) installed 
under the electrochemical cell. A voltage of −700 V was supplied to the PMT with a high 
voltage power supply (Model 472A Brandenburg PMT power supply, England). The 
light signal (as photocurrent) was detected with a high sensitive Keithley 6514 
electrometer (Keithley, Cleveland, OH, USA) and converted to voltage (in ±2 V) that was 
collected to the electrochemical workstation computer. Unlike the commercially available 
BioVeris ECL system, where flow-cell based ECL detection is used; our ECL instrument 
uses conventional electrochemical cells. For cathodic ECL measurements, the testing 
solutions were pre-degassed with ultra-high purity of nitrogen (Airgas South, 
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Hattiesburg, MS) for 7-10 min. All measurements were conducted at a temperature of 
23 ± 2°C. 
5.2.6 Confocal Microscopy 
ECL label loaded PSBs and PSB-virus-MB aggregates were imaged in a Zeiss 
LSM510 META confocal microscope (Carl Zeiss, NY). 
5.2.7 Transmission Electron Microscopy  
Transmission electron microscopy (TEM) images were obtained using a JEOL 
2100 transmission microscope operating at 200 kV. TEM images of ZIKV, PSB, and 
PSB<ZIKV>MB were obtained using copper mesh grids with Formvar support film. 
5.2.8 Real time-quantitative PCR (RT-qPCR) 
ZIKV particles attached on the surface of beads (i.e., PSB<ZIKV>MB) were 
quantified by RT-qPCR, as described previously.365 Briefly, PSB<ZIKV>MB complexes 
prepared with different concentrations of ZIKV were treated with TRI-reagent 
(Molecular Research Center) to lyse viral particles, and viral RNA was isolated after 
adding 1 μg of tRNA (ThermoFisher Scientific) as carrier. The complementary DNA 
(cDNA) was synthesized using the iSCRIPT cDNA synthesis kit (Bio-Rad) and RT-
qPCR assays were performed in a CFX96 Real-Time system (Bio-Rad) using iTaq 
universal probe supermix (Bio-Rad). Primers (Forward, 
GGAGTCAGCAATAGGGACTTTG; Reverse, CGGTTTGTCCTGTGCCATTA) and 
probe (FAM/AGGTGGGAC/ZEN/TTGGGTTGATGTTGT/3IABkFQ) specific to the 
Envelope gene of ZIKV were designed and synthesized by Integrated DNA 
Technologies. 
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5.2.9 Western blotting 
Antibody conjugation to beads was analyzed by immunoblotting as previously 
described.365 Briefly, the beads were treated with Laemmli sample buffer (Bio-Rad) and 
proteins were separated by 10% SDS-polyacrylamide gel electrophoresis, followed by 
transfer to a nitrocellulose membrane (Bio-Rad). Heavy chain and light chain of antibody 
were detected by probing the membrane with horseradish peroxidase conjugated goat 
anti-mouse IgG antibody (Jackson Immunoresearch). Images were acquired in a 
ChemiDoc MP system (Bio-Rad) by using SuperSignal West Pico Chemiluminiscence 
Substrate (Thermo Scientific). 
5.3 Results 
5.3.1 Assay design, ECL-label loading and antibody conjugation of polystyrene and 
magnetic beads 
A scheme of the ECL-based strategy for detection of viruses is shown in Figure 
5.1A, which is developed based on previous studies 155,156,161 with a more sensitive 
RUB/BPO sensing system. Briefly, the loading of ECL-labels (e.g., RUB) to PSBs 
amplifies the signal intensity several orders of magnitudes, generating a highly sensitive 
detection system. Subsequent conjugation of ECL label loaded PSBs with virus-specific 
antibody allow specific binding of virus particles to the PSBs surface. By using magnetic 
beads (MBs) conjugated with virus-specific antibody as a capture element, virus bound to 
ECL-label loaded PSBs can be separated magnetically and subjected to measurement of 
ECL-intensity after the dissolution of the PSB<virus>MB aggregates in MeCN, the latter 
signal is proportional to the amount of virus present in the samples. To develop a specific 
and highly sensitive ECL-based immunoassay for detection of ZIKV, PSBs were loaded 
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with RUB by immersing the beads into a saturated solution of RUB. These PSBs, 
designated as PSB(RUB), had a typical loading capacity of ∼3.3×109 RUB molecules per 
bead, which was estimated on the basis of the ECL data obtained from the PSB(RUB) 
dissolved in MeCN and a set of standard RUB solutions using BPO as a coreactant. ECL 
label loading of PSBs with RUB was confirmed with a fluorescence microscope, which 
shows that PSB(RUB) beads glow as intense yellow color when exposed to UV light 
(Figure 5.1B). No such signal was detected from unloaded (bare) PSBs (data not shown). 
Subsequently, avidin was covalently attached to the surface of the PSB(RUB) beads via 
amide bonding. Avidin conjugated PSB(RUB) beads then were mixed with a biotinylated 
monoclonal antibody (mAb ZV-2) that is specific to ZIKV and does not recognized 
closely related flaviviruses, including DENV (data not shown). This step generated an 
antibody-conjugated PSB(RUB) (abbreviated as anti-ZIKV-PSB in following text) for 
specific detection of ZIKV. In addition, magnetic beads (MBs) were conjugated with ZV-
2 mAb through biotin-streptavidin conjugation (anti-ZIKV-MB), which can serve as a 
capture element for magnetically separating ZIKV bound to PSB(RUB) in subsequent 
ECL-intensity measurements. Conjugation of ZV-2 to PSB (Figure 5.1C, left) and MB 
(Figure 5.1C, right) was confirmed by Western blotting. The ECL behavior of anti-
ZIKV-PSB complexes were studied. These complexes exhibited a stable and consistent 
ECL response similar to those shown in Figure 5.1C for RUB/BPO solutions, suggesting 
no alteration in ECL behavior of RUB after loading to PSB and antibody conjugation. 
Taken together, these data suggest that the anti-ZIKV-PSB complexes serve as both 
target binding reagent and ECL signal generator, and are suitable to capture ZIKV from 
solution.  
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Figure 5.1 Assay design and preparation of immuno-conjugated and ECL-loaded beads. 
Note: (A) Cartoon representation of fabrication of immunosensor for ZIKV and DENV4 (B) Image of rubrene loaded PSBs (golden 
yellow, right) taken under UV-light (385 nm excitation) in a confocal microscope. (C) Antibody conjugation to PSBs and MBs was 
analyzed by immunoblotting assay. Note: All experiments were performed in duplicates and repeated at least one time. 
5.3.2 Anti-ZIKV-PSB capture of ZIKV 
To test whether anti-ZIKV-PSB can capture ZIKV, 104 PFU of ZIKV (strain 
PRVABC59) in 0.1 M PBS (pH 7.4, 100 μL) containing 2% BSA were incubated with 
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anti-ZIKV-PSB (40 μL) for 45 min in a Dynal mixer to form ZIKV-anti-ZIKV-PSB 
complexes. These complexes were washed twice (8,000 g, 3 min) with PBS, re-
suspended in 100 μL PBS containing 2% BSA, then reacted with 10 μL of capture 
element (anti-ZIKV-MBs) for 45 min in a Dynal mixer form PSB<ZIKV>MB 
aggregates, which were separated by using Dynal magnetic separator. After 
centrifugation, some of the PSBs in the control samples (without virus) attach on the wall 
of the microfuge tube. In comparison, after addition of viruses followed by 
centrifugation, the virus-PSB complexes settled down at the bottom of microfuge tube 
(Figure 5.2A), indicating that the ZIKV causes aggregation of anti-ZIKV-PSBs. In 
addition, after magnetic separation, the beads that bound the PSBs can be observed in the 
wall of tube (Figure 5.2B), suggesting the formation of PSB<ZIKV>MB aggregates in 
the presence of ZIKV. As shown in a micrograph (Figure 5.2C), anti-ZIKV-PSB 
complexes undergo aggregation in the presence of ZIKV and anti-ZIKV-MBs. To detect 
and quantify the ZIKV bound to PSB<ZIKV>MB aggregates, different amounts of ZIKV 
(0 to 104 PFU) were used to form aggregates, which were separated magnetically and 
subjected to extraction and RT-qPCR analysis of ZIKV RNA. The PCR results confirmed 
that ZIKV bound to PSB<ZIKV>MB aggregates validating the efficiency of ECL-based 
assay to capture ZIKV (Figure 5.2D). Collectively, these results suggest that conjugation 
to ECL label loaded PSBs does not alter the specificity of anti-ZIKV antibody, 
suggesting that this system can be used to selectively capture the target ZIKV particles. 
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Figure 5.2 Immuno-conjugated and ECL label loaded polystyrene beads capture ZIKV. 
Note: (A) Photograph of a microfuge tubes after addition of ZIKV containing samples to ZV2-PSB(RUB), showing the aggregation of 
PSBs at the bottom of tube in the presence of ZIKV. (B) Photograph of a microfuge tubes after magnetic separation showing (arrow) 
the free MBs (right), and binding of PSBs to MBs (left) in the presence of ZIKV. (C) A phase-contrast image of 
PSB<ZIKV>MBaggregates showing the binding of anti-ZV2-MB (1 μm diameter, arrow) to the surface of anti-ZV2-PSB (10 μm 
diameter) in the presence of ZIKV. (D) PSB<ZIKV>MB aggregates that were obtained from samples containing different PFUs of 
ZIKV were analyzed by RT-qPCR assay to quantify copy number of ZIKV envelope gene. All experiments were performed in 
duplicates and repeated at least one time. 
Figure 5.3 shows TEM images during detection of ZIKV. More specifically, 
Figure 5.3 (A) shows white illumination of ZIKV under negative stain of 
phosphotungstic acid, indicating the ZIKV viral particle size was 40 nm. Figure 5.3 (B) 
shows only PSBs that are loaded with rubrene and coated with neutravidin, designated as 
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PSB(RUB)|avidin. Figure 5.3 (C) shows PSB<ZIKV>MB final aggregates showing many 
MBs attached to a PSB, and Figure 5.3 (D) is the zoomed image of PSB<ZIKV>MB final 
aggregate showing only one MB. 
 
Figure 5.3 TEM images during detection of ZIKV. 
Note: (A) white illumination of ZIKV under negative stain of phosphotungstic acid, (B) PSB(RUB)|avidin, (C) PSB<ZIKV>MB final 
aggregates showing many MBs attached to a PSB, and (D) zoomed image of PSB<ZIKV>MB final aggregate showing only one MB. 
5.3.3 Anti-ZIKV-PSB specifically detects ZIKV in a highly sensitive manner 
To detect ZIKV, anti-ZIKV-PSBs were mixed with different amounts of ZIKV (0 
to 104 PFU) diluted in PBS with 2% BSA. The resulting virus-PSB conjugates were 
washed to remove unbound viruses and re-suspended. Virus-PSB conjugates then were 
allowed to react with the capture element (i.e., anti-ZIKV-MB) to form sandwich-type 
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PSB<ZIKV>MB aggregates, which were magnetically separated from the reaction 
medium. PSBs that did not have bound viruses do not form aggregates and remain in 
solution during magnetic separation. Thus the ECL-intensity obtained from the 
PSB<ZIKV>MB aggregate is proportional to the concentration of virus in a sample. 
Figure 5.4A shows that the ECL intensity of the purified MB-ZIKV-PSB aggregates 
increase with the amount of virus in the samples. Notably, the ECL response obtained 
from sample containing 1 PFU of ZIKV is distinguishable from the background (i.e., no 
virus in the system), indicating that the present detection platform has a detection limit of 
as low as 1 PFU, which is comparable to RT-PCR (see Figure 5.2D). If the concentration 
of virus in a sample is low, the amount of PSB-virus-MB species formed should be also 
low. In this case, most of the ECL-signal remains in free (virus-unbound) PSBs that are 
left in solution during magnetic separation. To confirm these results, the ECL intensity of 
virus-free PSBs was measured, which was expected to be complementary with the ECL 
signals obtained from PSB-virus-MB aggregates. Indeed, the ECL signals from the virus-
unbound PSBs displayed an inversed relationship with the original amount of ZIKV 
added to samples (Figure 5.4B). This was expected, because each sample used the same 
amount of PSBs; the more PSB<ZIKV>MB aggregates are formed, the less PSBs remain 
in the solution. These results also show that there is no loss of ECL-intensity during the 
assay, confirming that the ECL-intensity of PSB-virus-MB is proportional to the amount 
of complex formed, hence the amount of virus present in the samples. To analyze further 
the relationship between ECL-intensity and the amount of virus in the samples, area 
under the ECL-curves were calculated and plotted the average values against the amount 
of virus added to the samples. The results showed a linear relationship between the virus 
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amount and the ECL-intensity of PSB<ZIKV>MB aggregates as well as free PSBs in the 
supernatant (Figure 5.4C). These results suggest that the ECL-intensity proportionally 
reflects the amount of viral particles present in samples in a sensitive manner. 
To determine whether anti-ZIKV-PSB specifically binds to ZIKV, unrelated 
(chikungunya virus (CHIKV)) or related (West Nile virus (WNV) and dengue (DENV, 
serotype 1-4)) mosquito-transmitted viruses were tested with the developed ECL-based 
immunoassay. As shown in Figure 5.4D, the ECL-intensity of samples containing 103 
PFU of CHIKV, WNV, or DENV has a substantially lower ECL signal as compared to 
ZIKV. The inset of Figure 5.4D illustrates the normalized ECL intensity of six viruses 
compared to ZIKV, and suggests that the detection of ZIKV by an anti-ZIKV-PSB based 
immunoassay has an acceptable selectivity of ~90%. In addition, ECL label loaded PSBs 
and MBs were conjugated with a mAb (4G2) that binds to the conserved fusion loop 
epitope of the E protein of most flaviviruses.366 The stability of the ECL-based 
immunoassay based on PSB<ZIKV>MB system is actually determined by the stability of 
the RUB/BPO ECL system, because trace amounts of PSB and MB debris as well as bio-
substances present in MeCN solution do not interfere the ECL generation. Stable and 
reproducible ECL signals were observed from the same test solution over different 
potential cycles and on different testing days. 
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Figure 5.4 Anti-ZIKV-PSB specifically detects ZIKV in a highly sensitive manner. 
Note: Samples containing different amounts of ZIKV (0-104 PFU) were prepared in PBS containing 2% BSA and allowed to form 
PSB<ZIKV>MB complexes by reacting with ZV2-PSB(RUB) and ZV2-MB. PSB<ZIKV>MB complexes were separated 
magnetically and subjected to ECL-intensity measurement. (A) ECL-response curves of PSB<ZIKV>MB aggregates obtained from 
samples containing different PFUs of ZIKV in PBS. (B) ECL-response of free (unliganded) PSB(RUB) that remained in solution after 
magnetic separation. (C) A calibration curve of mean ECL intensity of magnetically separated PSB<ZIKV>MB aggregates (upward 
line, black) and free PSB(RUB) (downward line, blue) that remained in solution after magnetic separation. (D) ECL response of 
PSB<ZIKV>MB aggregates obtained from samples containing related (DENV and WNV) or unrelated (CHIKV) viruses (103 PFU) 
prepared in PBS containing 2% BSA. Sample containing no virus was used as a control to determine background signal (~0, see 
Figure 5.4C). All experiments were performed in duplicates and repeated at least one time. 
5.3.4 ECL-based immunoassay can detect ZIKV in human biological fluids 
ZIKV is present in human blood, urine and other body fluids.339,340,367 To test 
whether our ECL-based immunoassay can detect ZIKV in human body fluids, we 
collected plasma and urine specimens from healthy human volunteers and spiked in 
different amount of ZIKV. In these samples, we performed ECL-based immunoassay and 
measured the ECL-intensity of PSB<ZIKV>MB aggregates. Consistent with the results 
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obtained in PBS, our ECL-based assay detected as few as 1 PFU of ZIKV in 100 µL of 
human urine (Figure 5.5A) and plasma (Figure 5.5B). These results were complemented 
by measuring the ECL intensity of virus-free PSBs that remain in solution after magnetic 
separations (Figures 5.5C and 5 5D), which show a progressive decrease of ECL-
intensity with increasing amount of ZIKV present in samples. The area under the ECL 
curves were plotted against amount of PFUs added to the samples (Figures 5.5E and 
5.5F) and produced a linear curve, suggesting that the ECL-intensity of the PSB-virus-
MB aggregates formed is proportional to the amount of ZIKV in the sample. These 
results establish that the ECL-based immunoassay can detect ZIKV in clinical samples in 
an ultrasensitive and specific manner. 
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Figure 5.5 ECL-based immunoassay detects ZIKV in human biofluids. 
Note: Samples containing different amounts of ZIKV (0-103 PFU) were prepared in human urine or plasma specimens collected from 
healthy human volunteers. ECL-response from PSB<ZIKV>MB aggregates obtained from (A) plasma, and (B) urine samples 
containing different PFUs of ZIKV. ECL-response of virus-free PSB(RUB) that remained in solution after magnetic separation from 
(C) urine and (D) plasma samples. A calibration curve of mean ECL intensity of magnetically separated PSB<ZIKV>MB aggregates 
(upward line, black) and free PSB(RUB) (downward line,blue) that remained in solution after magnetic separation were generated 
from (E) urine and (F) plasma samples. No virus control was used to determine background signal. All the experiments were 
performed in duplicates and repeated at least one time. 
5.3.5 ECL Detection of DENV4 
For the detection of DENV4, similar strategy to the ZIKV detection as described 
above was used, where the experimental conditions and the procedures remained the 
same but the antibody was changed to anti-4G2 that detects most of the flaviviruses. 
Experimentally, the samples containing different amounts (0-104 PFU) of DENV4 in PBS 
containing 2% BSA were allowed to form PSB<DENV4>MB aggregates by reacting 
with anti-4G2-PSB(RUB) and anti-4G2-MB. The final PSB<DENV4>MB aggregates 
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were dissolved with 2.0 mL of 10.0 mM BPO followed by ECL measurements after 
degassing with N2. 
Figure 5.6 shows the photographs of centrifuge tubes at different stages of 
DENV4 detection. More specifically, Figure 5.6A shows the PSB-DENV4 conjugates 
before MB separation, where large numbers of DENV4 correspond to more precipitates 
of PSB-DENV4 conjugates at the bottom of the tube. Figure 5.6B shows that the spot 
size of PSB<DENV4>MB aggregates on the wall of the tube progressively decreases 
with the decrease of DENV4 concentration. This is expected, because the less numbers of 
DENV4 are, the less conjugates of PSB-DENV4 are formed, and the less numbers of 
PSB<DENV4>MB aggregates can be collected. Consistent with the above observations, 
the number of free unbound PSB(RUB) beads collected from the supernatant increase 
with the decrease of DENV4 concentration as illustrated in Figure 5.6C.  
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Figure 5.6 (A) PSB(RUB)-anti-4G2 conjugates, (B) PSB(RUB)<DENV4>MB final 
aggregates and (C) Free (unbound) PSB(RUB) from the supernatant. 
The final aggregates of PSB<DENV4>MB shown in Figure 5.6B were dissolved 
in 2.0 mL of 10.0 mM BPO and subjected to ECL measurements. Figure 5.7A shows the 
ECL-potential profiles of solutions associated with different concentrations of DENV4, 
where progressive increase of ECL signal along with the increase of DENV4 
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concentration is generally seen. Figure 5.7B displays the linear relationship between the 
integrated ECL intensity and the logarithmic concentration of DENV4, where the upward 
line is obtained from the solution containing dissolved PSB<DENV4>MB aggregates, 
and the downward line corresponds to the solution containing dissolved free PSB(RUB) 
that remained in solution after magnetic separation. Because a constant number of 
PSB(RUB) was used for each DENV4 test, an opposite ECL intensity change is expected 
from the test solution associated with PSB<DENV4>MB aggregates and free PSB(RUB) 
beads. Notably, the ECL signal of 1 PFU DENV4 can be clearly distinguished from the 
background, indicating a limit of detection of 1 PFU/100 mL DENV4 with the present 
ECL method. 
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Figure 5.7 ECL-responses from PSB-DENV4-MB aggregates obtained from samples 
containing different concentrations of DENV4 viruses. 
Note: (A) Samples containing different amounts (0-104 PFU) of DENV4 in PBS containing 2% BSA were allowed to form PSB-
DENV4-MB aggregates by reacting with anti-4G2-PSB(RUB) and anti-4G2-MB. All the experiments were performed in duplicates 
and repeated at least one time. (B) Plot of a calibration curve of mean ECL intensity of magnetically separated PSB<DENV4>MB 
aggregates (upward line, black) and free PSB(RUB) (downward line, blue) that remained in solution after magnetic separation were 
generated in PBS buffer. 
5.4 Discussion 
Mosquito transmitted viruses, such as DENV, Japanese encephalitis virus, and 
WNV are worldwide public health challenges.368 Recent emergence of CHIKV 369 and 
ZIKV 370,371 has prompted a global public health emergency. Besides mosquito 
transmission, these viruses also can be transmitted through other routes, such as blood 
transfusion, organ transplantation, and in utero.372,373 For instance, ZIKV virions or RNA 
can be detected in semen, urine, and saliva, and is categorized as a high-priority 
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infectious agent with the risk of sexual-transmission.342-344 Importantly, there is no 
approved vaccine or specific therapy against the most of these mosquito-transmitted 
viruses. Early and accurate diagnosis of viral infection can reduce the risk of severe 
consequences, such as DENV hemorrhagic fever, shock syndrome and ZIKV-related 
developmental defects. Most of the currently available diagnostic methods for viral 
infection are based on detection of viral antigens, antiviral antibodies, or viral nucleic 
acid. Although the nucleic acid-based methods are sensitive, they require expensive 
reagents and instruments. For immunoassays, the performance is often poor due to cross-
reactivity with other flaviviruses (e.g. Dengue) and difficulty in clinical correlation. 
Direct detection of viruses is challenged by requirement of facilities, such as cell culture 
or electron microscopy, which are not available in most diagnostic laboratories. Thus, a 
rapid, simple-to-use, sensitive, and cost-effective assay for virus detection in clinical 
specimen is highly desirable.  
An ECL-based detection assay may be ideal for virus detection as it offers several 
advantages including ultrasensitivity, reproducibility, cost-effectiveness, and rapidness 
over conventional immunoassays and PCR-based assay,85,374,375 as demonstrated in this 
chapter for detection of ZIKV and DENV4 in human biological fluids. Moreover, as 
ZIKV has been suggested to be transmitted by blood transfusion, the ECL-based assay 
could be developed for blood screening of ZIKV. By utilizing various ECL-emitters 
(such as RUB, Ru(bpy)3
2+, and DPA) that have easily distinguishable excitation and 
emission properties,376 ECL-based immunoassays have multiplexing capacity for 
simultaneous detection of several types of viruses in a single sample. 
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5.5 Conclusion  
Ultrasensitive ECL based immunoassays were fabricated for sensitive and 
specific detection of zika virus (ZIKV) and dengue virus (DENV4) in human body fluids. 
As low as 1 PFU/100 μL or 10 PFU/mL of ZIKV and DENV4 were detected using 
sensitive RUB/BPO ECL system in MeCN. This was achieved by amplifying the ECL 
signal using two particles (beads) assay using polystyrene bead as ECL label carrier 
whereas magnetic bead as conjugates or aggregates separation moderator. This proof-of-
concept study can be extended to the detection of other viruses or pathogens. 
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CHAPTER VI – CONCLUDING REMARKS 
 
Electrogenerated chemiluminescence (ECL) is a process of light emission at the 
surface of the working electrode resulting from electrochemical and chemical reactions of 
the ECL emitters (labels) with or without the use of deliberately added ECL coreactants. 
ECL is electrode potential controlled. ECL is “on” when potential is applied and ECL is 
“off” once the potential is disconnected. For the process of ECL to be relatively efficient 
or ECL to be strong (ECL intensity in the scale of microampere range scale when 
micromolar concentrations of ECL emitters are used), the electrogenerated emitter 
radicals must be sufficiently stable in the reaction media. The highly efficient ECL could 
be produced by adding coreactants that allow the ECL process to occur upon either 
anodic potential scanning or cathodic scanning. ECL can be detected by using various 
light detectors coupled with or without wavelength selectors including photomultiplier 
tube (PMT), charge coupled devices (CCDs), and complementary metal–oxide–
semiconductor (CMOS). Thus, ECL can also be understood as a marriage between 
electrochemistry and spectroscopy. Most diagnostic methods are often challenged by 
three factors—sensitivity, selectivity and stability of the biosensor. ECL based biosensors 
are promising when addressing these issues.  
After an introduction chapter of the dissertation (Chapter I), systematic ECL 
studies of unmixed and mixed systems of three most efficient ECL emitters, namely, 
9,10-diphenylanthracene (DPA), rubrene (RUB), and tris(2,2'-bipyridine)ruthenium(II) 
complex (Ru(bpy)3
2+), using benzoyl peroxide (BPO) as a common cathodic coreactant 
and 2-(dibultylamino)ethanol (DBAE) or tri-n-propylamine (TPrA) as an anodic 
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coreactant in acetonitrile, were studied for their potential applications in multiplexing 
ECL detection of multiple target analytes (Chapter II). The experiments were performed 
with a homemade, portable, and inexpensive spectral ECL instrument. The search for 
most favorable coreactant turned out to be the cathodic coreactant BPO among tested 
coreactants of DBAE, TPrA, and BPO. Certain interactions associated with energy 
transfer were observed when different ECL emitters were mixed in the same system, 
which was confirmed by fluorescence titrations and consistent with their emission and 
absorption spectra. The experiments and spectral ECL instrument can be well-adapted by 
college level chemistry laboratories especially senior undergraduate analytical chemistry 
and instrumental analysis courses.  
In Chapter III, an extension of the study done from Chapter II was explored. 
Synthesis, electrochemistry, and ECL studies of water soluble analogues of DPA and 
RUB were carried out. Different ECL coreactants and electrode materials on the ECL 
behavior of sulfonated DPA (DPAS), sulfonated RUB (SRUB), and Ru(bpy)3
2+ were 
systematically examined. DBAE and Pt electrode were found to be most favorable 
coreactant and electrode, respectively. The relatively weak ECL responses can be 
remarkably enhanced by adding 10.0 mM nitrate salt to the ECL system. The proposed 
mechanism involving the production of NO3
• free radicals, which chemically reacted with 
ECL emitter and coreactant to form species crucial for ECL production. Electron spin 
resonance spectroscopy (EPR) experiments with solution phase KNO3 mixed with spin 
trapping agent DMPO under UV irradiation provided direct evidence of the existence of 
such a free radical. ECL titration studies of mixed systems of the emitters using DBAE 
and nitrate salt were also carried out. 
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In Chapter IV, EPR studies of radical intermediates (C6H5COO
• and SO4
•-) of 
cathodic ECL coreactants benzoyl peroxide (BPO) and persulphate salt were presented. 
Several strategies were used for the generation of radicals, which included solid and 
solution phase coreactant with and without DMPO under UV irradiation and chemical 
reductions of coreactants with hydrazine. These data provided direct evidence that 
supports various ECL mechanisms proposed previously, although detailed explanation or 
interpretation of such EPR spectra are yet to be done.  
In Chapter V, sensitive and selective detection of viruses, namely zika virus 
(ZIKV) and dengue virus (DENV4) was reported using two particles (beads) based ECL 
immunoassay, where polystyrene bead was used as ECL label carrier and magnetic bead 
as conjugate or aggregate separation moderator. The loading of ECL label rubrene inside 
the polystyrene allowed huge amplifications resulting in sensitive detection of viruses 
(DENV4 and ZIKV) with a LOD of 10 plague forming unit (PFU)/mL or 1 PFU/100 μL 
sample. 
One of the important future direction of the studies can lead to the application of 
the studied multiple efficient emitters and coreactants for multiplexed assays for 
detecting multiple analytes simultaneously. For example, using two efficient ECL 
emitters DPA and RUB with effective combination of cathodic ECL coreactant BPO 
could generate ECL at two distinct emission wavelengths of ~420 nm and ~550 nm, 
respectively, for the detection of two analytes of interest simultaneously without pre-
separation.
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